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 Intense interest is being focused on self-assembling biological networks and their practical 
applications, making them powerful tools for the next-generation of advanced bionanomaterials. 
This thesis project explores potential strategies to fabricate versatile protein networks in a 
supramolecular fashion. That will create a functionalized scaffold through the chemical attachment 
of a diverse range of molecules such as: enzymes, magnetic nanoparticles, and photolabile-based 
drugs.  
The thesis hypothesis was that advanced bionanomaterial scaffolds could be fabricated 
from capsule proteins and linkers employing the high affinity biotin-avidin interaction. This bio-
based platform leverages a cage-like proteinaceous molecule, which is ferritin. The protein ferritin 
is expressed in the tissues of many life forms and it features a rigid spherical structure with robust 
biochemical and thermophilic properties making it an attractive component for three-dimensional 
protein network design. Bioconjugation is an important tool in the fabrication of complex 
bionanomaterials.  
The ferritin capsule protein was incorporated in the network by implementing bioconjugate 
techniques on its exterior surface, where the lysine residues were the main focus to undergo 
reactions on in order to display free biotin molecules on the protein’s surface. These biotins, along 
with the protein avidin, a protein having high affinity to biotin, self-associate via avidin-biotin 
complexation, and form the basis of a cross-linked network.  
A wide range of PEGylated molecules were investigated to surface-modify ferritin to 
showcase the potential for functional diversity. Additionally, a multi-step bioconjugation strategy 
was developed to successfully tag ferritin with aldehyde-containing molecules, which can add 
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further novelty to the protein network. The designed and functionalized networks that are 
demonstrated in this research could potentially be capable of serving as a multi-enzyme protein 
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1  Chapter 1: Introduction to Bioconjugation and Protein Networks 
1.1 The Ferritin Protein Superfamily  
1.1.1 Ferritin Properties and Architecture 
The ferritin protein family is a class of multimer capsule proteins found ubiquitously in 
numerous organisms such as bacteria, archaea, and eukaryotes – with the exception of yeast (Zang 
et al., 2017) (Jutz et al., 2015) (Putri et al., 2015). The ferritin protein family typically has a highly 
preserved cage structure, although significant variations in the primary sequence, as much as 80%, 
are found among some ferritin subfamilies (Zang et al., 2017) (Theil, 2013). Ferritin’s quaternary 
structure has twenty-four structurally-identical subunits. Each subunit reveals a bundle structure 
of four parallel alpha-helices (helices A-D), in addition to a short helix at the C-terminus coded by 
helix E (Figure 1.1) (Zhang & Orner, 2011). Each subunit has a molecular weight of approximately 
19-21 kDa summing up to ~480 kDa when assembled as a 24-mer. The four parallel alpha-helices 
found in ferritin are structurally similar to the alpha-helices found in methane monooxygenase, 







Figure 1.1. Regular ribbon structure of a bacterioferritin (PDB: 1BFR) monomer exhibiting the 
alpha-helical bundle. A-C and E helices are shown in distinct colors. Reproduced with 
permission under CC license from (Zhang & Orner, 2011). 
 
The ferritin protein has an inner and outer diameter of 8 nm and 12 nm respectively (Figure 
1.2). The C-terminal end of each monomeric HSF subunit folds towards the interior cavity of the 
capsule protein, while the N-terminal end extends to the outer surface of it. The N- and C-termini 
of ferritins are interesting sites for biochemical functionalization where molecular tags could be 
fused specifically onto them. Ferritin extracted and purified from mammalian tissues possess 
heavy (H) and light (L) chain subunits in the same quaternary structure, and their exact molecular 
weight and composition is diverse among different species and organs that they were isolated from, 
while the bacterial ferritins consist of only one type of subunit. The H-chain was found to facilitate 
the initial binding then oxidation of cellular iron. The L-chain subsequently contributes to the 
nucleation of ferrihydrite allowing it to migrate into the ferritin cage (Theil, 2013). Furthermore, 
the structural identity of the protein revealed eight C3 channels with hydrophilic properties and six 
C4 channels with hydrophobic properties (Jiang et al., 2020). An illustration of the ferritin 





Figure 1.2. Ribbon representation of human ferritin. The structure of ferritin resembles a 24-mer 
self-assembled symmetrical cage protein with 8 and 12 nm diameter dimensions, two types of 
chains (heavy and light) and two channels (C3 and C4) (PDB: 5N27). Reproduced with 
permission under CC license from (Jiang et al., 2020). 
 
Ferritin contributes to the reversible iron homeostasis in the cell and reduces oxidative 
stress (Orino et al., 2001). The excessive concentration of iron, Fe (II), in the cell leads to iron 
toxicity and results in the rise of reactive oxygen species (ROS) since iron catalyzes the Fenton 
reaction producing ROS that causes cell death (Kajarabille & Latunde-Dada, 2019). To avoid iron 
participation in this redox reaction, ferritin’s primary function is to trap iron Fe (II) into the interior 
cavity of the protein’s spherical cage to oxidize it to insoluble Fe (III) and store it in this non-toxic 
form until it is needed by the cell. The core stores iron as the inorganic ferrihydrite abbreviated by 
(FeOOH)x and it could also contain phosphate. The interior centre of ferritin is a crucial part of 
the overall protein design since each capsule has the capacity to accommodate up to 4500 iron 
atoms inside the inner cavity (Harrison, 1986). The iron-free spherical protein shell version of 
ferritin is termed Apoferritin. 
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Ferritin is water-soluble and remarkably stable at extremes of pH and temperature 
conditions. The pH range where ferritin functions well while remaining in its quaternary structure 
is pH 3-10. A complete declustering of the 24-mer ferritin capsule assembly to monomers was 
recorded only at pH 2 and 11 (Zang et al., 2017). Moreover, this protein is thermostable, where 
some ferritins can endure high temperatures up to 85 °C (Schoonen & Van Hest, 2014).   
Commonly, ferritins have a relatively acidic isoelectric point (pI) of 5.0-6.0, because their 
interior surfaces are rich with aspartate and glutamate which results in negative net charge of the 
interior cage (Zang et al., 2017). However, the exterior surface is not as acidic. Studies have shown 
that the net charge of the ferritin exterior shell is close to neutral or a little positive when at pH 7.0 
(Zhao, 2010), (Figure 1.3). The acidic environment of the cavity makes it possible for positively 
charged nanoparticles, metal ions, or therapeutic organic molecules to diffuse through the 
nanopore channels of the ferritin shell via electrostatic interaction. This feature raises interesting, 
and also vital applications in the nanomaterials and medicinal chemistry disciplines.  
 
Figure 1.3. Interior surface of ferritin has a net negative charge, indicated by the dominant red 
color of the acidic amino acid residues. B) Exterior surface of ferritin with a charge close to 
neutral. Reproduced with permission under CC license from (Zhao, 2010). 
 
The members of the ferritin superfamily acquire their name based on the organism from 
which the ferritin was isolated, such as human heart ferritin, horse spleen ferritin, bacterioferritin 
5 
 
(from Escherichia coli), Pyrococcus furiosus ferritin, and Archaeoglobus fulgidus ferritin. For 
years, the research in the Honek laboratory has focused on studying and exploring different 
subtypes of ferritin to construct potentially useful nanomaterials. In our research, horse spleen and 
Pyrococcus furiosus ferritins were the focus and will be discussed in further detail.  
1.1.2 Description of Horse Spleen Ferritin and its Structural Features 
The very first kind of the ferritin protein was discovered and isolated in 1937 from equine 
spleen by developing a unique purification method that employed cadmium sulphate salt 
precipitation (Laufberger, V. 1937). The crystal structure of horse spleen ferritin (HSF) was not 
solved until 1991, revealing two types of subunits with a high degree of homology, the H-chain 
and L-chain with a molecular weight of 21 and 19 kDa respectively, assembled to create a 24-
meric capsule with octahedral symmetry (Lawson et al., 1991).  
HSF is exceptionally stable under many different conditions. Therefore, it remained a good 
choice as a capsule protein for biochemical studies. HSF can preserve its quaternary structure, 
resisting denaturants such as urea and guanidinium chloride (GdnHCl) up to 6.0 M in the aqueous 
solution (Listowsky et al., 1972). More interestingly, the dissociation of HSF subunits was found 
to require 7.0 M of GdnHCl at pH 7.5, which is a sufficiently high concentration to denature a 
wide range of proteins (Listowsky et al., 1972).  
The exterior surface of horse spleen ferritin provides a framework of various amino acid 
residues as reactive sites that can undergo cross-linking reactions in order to modify the surface of 
the protein. Lysine residues are commonly targeted for protein surface modification, in addition to 
cysteine residues. HSF is abundant with surface-exposed lysine residues. It was found that HSF 
6 
 
has a total of nine lysine residues in each subunit (PDB: 5ERK), three of which (K83, K97, K104) 
are exposed on the outer shell and available for modification (Figure 1.4).  
 
Figure 1.4. Structural model representation of one HSF subunit coloured in yellow, with 3 
lysines coloured in red, exposed to the exterior surface. Structure was created using Chimera 
software employing protein structure PDB: 5ERK. 
 
1.1.2.1 Carbohydrate Composition of Ferritin    
It is well established that a variety of proteins undergo post-translational modifications to 
form a mature protein product following the biosynthesis by ribosomes. Glycosylation is a type of 
post-translational modification that is present in ferritin proteins isolated from different tissue 
sources. The carbohydrate content is essential in many protein-based biopharmaceutical drugs and 
intracellular proteins, where the sequence, number of glycans, and their correct attachment to the 
amino acids are crucial for targeting functionality, immunogenicity, folding, stability, and 
pharmacokinetics of the drug (Zhong & Wright, 2013).  
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Studies have reported that horse spleen ferritin is a glycoprotein, hence it possesses 
microheterogeneity in its structure (Arosio et al., 1978) (Urushizaki et al., 1971). For instance, 
ferritin can bind to the lectin, Concanavalin A, a mannose/glucose binding protein, which confirms 
that carbohydrates are present. Another clue that supports the heterogeneity of ferritin is an earlier 
isoelectric focusing study conducted on ferritin isolated from different horse organs. This work 
revealed several discrete and heterogenous isoelectric bands ranging from 4.1 to 5.1 (Arosio et al., 
1978), that is close to a previous pI range of 4.22 to 4.6 obtained by Urushikazi and colleagues 
(Urushizaki et al., 1971). The change in the isoelectric point could be a manifestation of post-
translational modification, and then to protein heterogeneity (Arosio et al., 1978). 
Qualitative and quantitative analyses have targeted the carbohydrate residues on horse 
spleen ferritin to explore their exact composition and number. Research reported by Shinjyo et al.   
discovered 15 molecules of hexose, 10 of fucose, and 1 hexosamine on each ferritin molecule 
(Shinjyo et al., 1975). Several different methods were employed to determine the number of 
hexoses, fucoses, and hexosamines and included the phenol/H2SO4 method, the Gibbons method, 
and the Blix method, respectively (Shinjyo et al., 1975). To discover the identity of the hexoses 
that were present, techniques such as thin layer and gas chromatography were employed with 
comparison to known standards, and analysis of the data showed that both epimers, mannose, and 
galactose are present in a molar ratio of 2:1. The study observed a different number of determined 
hexoses per mole of molecules when the ferritin structure is disrupted. The intact horse spleen 
ferritin showed a quantity of 15 hexoses, which increased to 25 hexoses after denaturation. Shinjyo 
et al. suspects that the denaturation of the ferritin has enabled all the hexose residues to be released 
from the protein shell (Shinjyo et al., 1975). This leads to microheterogeneity of the capsule protein 
surface since fucose and hexosamine represent less than 1 carbohydrate residue per subunit. As to 
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the carbohydrate composition, ferritin has non-identical subunits, by which the distribution of 
carbohydrate residues varies in each subunit.  
Other studies also detected the presence of carbohydrate attached to the protein, but with 
some variation. A research report by Munro & Linder indicated that the carbohydrate molecular 
composition in the same protein was comprised of: 16 hexoses (6 mannose and 10 galactose), 7 
fucose, and 38 glucose residues comprising 2.4% of the total molecular weight of the spleen and 
liver apoferritin (Munro & Linder, 1978). Both ferritin and apoferritin were reported to have the 
same carbohydrate composition. It was suspected that these carbohydrate molecules are added 
only to ferritin subunits that are made by membrane-bound ribosomes and that is due to the 
presence of glycosylation enzymes near the endoplasmic reticulum membrane (Munro & Linder, 
1978).  
Glycosylation has been found to be associated with ferritin L-chains only. The 
carbohydrates lay at the exterior of the assembled protein, according to previous experimental 
work (Harrison, 1986). Each horse spleen ferritin subunit has a single N-linked glycosylation 
(Harrison, 1986), the type usually found in eukaryotic cells, which are commonly located at the 
sequence, Asn-Z-Ser/Thr where Z is any amino acid residue except proline (Zhong & Wright, 
2013). Horse spleen ferritin’s N-glycosylation sequence is consistent with that, by which the 
oligosaccharides were found to be at Asn(7)-Tyr(8)-Ser(9), (Harrison, 1986).  
Raman spectroscopy was employed by a group of researchers to detect the presence of 
glycosylation on the horse spleen ferritin surface (Ashton et al., 2017). It is feasible to distinguish 
between the Raman spectra of glycosylated and non-glycosylated forms of the protein. Both 
quantitative and qualitative carbohydrate assessment of horse spleen ferritin proteins is achievable 
by Raman spectroscopy, where it was possible to have an accurate measurement for the 
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concentration of glycosylated ferritin using the generated spectroscopic data sets (Ashton et al., 
2017). 
1.1.3 Description of Pyrococcus furiosus Ferritin and its Structural Features 
The thermally stable Pyrococcus furiosus ferritin (PfFtn) is a ferritin protein expressed by 
a hyperthermophile archaeon that is extremely stable even up to the high temperatures beyond the 
boiling point of water. Crystal structures of ferritin from archaea are limited. Only two ferritin 
protein structures from an archaeon source have been determined to date, the Archaeoglobus 
fulgidus ferritin (AfFtn) and the Pyrococcus furiosus ferritin (PfFtn). The PfFtn protein subunit 
exhibits the typical structural motif of a four alpha-helical (helices A-D) bundle (Honarmand 
Ebrahimi et al., 2013). PfFtn’s quaternary structure is composed of 24 identical subunits, each with 
a molecular weight of 20 kDa, which is encountered similarly in known bacterial and eukaryotic 
ferritins. The PfFtn primary sequence is rich in lysine residues, with 15 lysines found in each 
subunit, and 10 of these lysines (K8, K75, K78, K85, K95, K99, K112, K135, K142, K145) are 
surface exposed for potential modification. A structural illustration of PfFtn employing PDB: 
2JD7, is shown in (Figure 1.5). It should be noted that Pyrococcus furiosus ferritin lacks the short 
helix-E that is present in horse spleen ferritin and bacterioferritin (Andrews, 2010). The isoelectric 
focusing point of PfFtn has also been explored in prior studies. Apoferritin and iron-loaded PfFtn 
were both examined and had the same value of pI = 4.5 (Tatur et al., 2006), which is in the range 




Figure 1.5. Structural model representation of P. furiosus highlighting one subunit in yellow. 
One subunit contains 10 lysine residues coloured in red, which are exposed to the exterior 
surface. Structure was created using Chimera software employing protein structure PDB: 2JD7. 
 
Pyrococcus furiosus ferritin is an extremely thermostable archaeon protein that can 
withstand 24 hours in vitro incubation at 100 °C and autoclaving for some time at 120 °C and still 
maintaining its three-dimensional structure with no loss of the iron (Fe II) uptake activity (Tatur 
et al., 2006). PfFtn appeared to be the most stable ferritin that has been isolated so far. The 
thermostability of PfFtn in comparison to eight structurally similar ferritins was studied in order 
to investigate the factors involved in the resistance to thermal denaturation. The work done by 
Kannan & Vishveshwara revealed a cumulation of various factors such as hydrogen bonding, salt 
bridges, van der Waal interactions and the order of the primary amino acid sequence, more charged 
amino acid population, and fewer uncharged polar amino acids (Kannan & Vishveshwara, 2000). 
Other listed factors highlighted the presence of higher β-strand content, more hydrophobic β-
branched amino acids (Eidsness et al., 1997). All of these factors together are believed to contribute 
to thermal stability of ferritin proteins, and many tend to appear in PfFtn. Furthermore, it appears 
that the preservation of the monomeric unit is very important to obtain protection from heat 
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denaturation, owing to the abundant number of intra-molecular/subunit hydrogen bonds between 
the atoms in the main chain and side chain (Tatur et al., 2007). Additionally, a former study by the 
same researcher tested the P. furiosus ferritin protein stability against several freeze-thaw cycles 
that are capable of damaging protein structure, which any biochemist is familiar with. 
Interestingly, the P. furiosus ferritin exhibited no drop in activity after three cycles (Tatur et al., 
2006).   
Scientists realized that the astonishing thermostability of PfFtn has an important value that 
is worth exploring and can effectively serve in biotechnological applications. A previous report 
investigated the utility of the thermally stable ferritin, PfFtn, as a biological template to synthesize 
inorganic nanoparticles while encapsulated inside the protein cage. The synthesis and 
encapsulation was achieved successfully at a temperature up to 120 °C while maintaining a 
capsule-like architecture of the PfFtn (Parker et al., 2008). Several studies have reported that the 
P. furiosus ferritin can be an excellent choice of template for controlled silver biomineralization 
(Kasyutich et al., 2010), for nano-sized palladium biocatalytic machines (Kanbak-Aksu et al., 
2012), and for the efficient removal of arsenate and phosphate from drinking water (Sevcenco et 
al., 2015).  
1.2 Bioconjugation Chemistry and Strategies 
Chemical modifications of macromolecules afford powerful tools to study a broad range of 
complex biological systems and to develop many exciting applications in protein research, 
pharmaceutical science, and nanomaterial science. This makes bioconjugation chemistry an 
attractive and desirable scientific technique. Many strategies have been employed to link various 
chemical probes of interest to target native proteins in a site-selective manner. Chemical probes 
that can be attached to proteins, such as cross-linking reagents, affinity labels, and fluorescent 
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dyes, will result in protein-conjugate hybrids serving as powerful tools in proteomics related 
applications. Modern methodologies are being developed to exploit these versatile bioconjugation 
strategies for the support of human needs. As examples, fluorescent dye labelling for medical 
imaging (Zhu et al., 2017), prolonging therapeutic protein lifetime by polyethylene glycol surface 
labelling (Dozier & Distefano, 2015), or constructing protein-based biosensors (Dai et al., 2018), 
and more have been realized. 
Visualization of live cellular processes such as protein expression levels, trafficking, and the 
change in protein folding states, are possible by utilizing the bioconjugation techniques 
intracellularly. These techniques include protein fusions, tyrosine ligation, biotinylation, 
fluorescein arsenical helix binder (FlAsH), and many others, which are used to observe proteins 
as the biological event is occurring (Moghaddam-Taaheri & Karlsson, 2018).  
Furthermore, an interesting area in bioconjugation is the development of protein-
oligonucleotide conjugates (POCs) and the application of these molecules has become widespread 
in recent years. The bioconjugation of proteins and DNA has demonstrated novelty in the area of 
bionanomaterials. Given the fact that the DNA is a programmable molecule, it allows the 
integration of multivalent peptides to be displayed in the biomaterial, in addition to the ability to 
control the nanoscale spacing between the multiple peptides within this scaffold. The peptide-
targeted binding is directed by employing a heterobifunctional cross-linker to link peptides on one 
side, via the cysteine thiol group of one peptide, with the DNA molecule on the other side that has 






Figure 1.6. DNA-peptide biomaterials. A) DNA-peptide bioconjugate. B) A self-assembled 
tetrahedral cage of DNA strands, manifesting peptide conjugation to the DNA scaffold. 
Reproduced with permission from (Stephanopoulos, 2019). 
 
Materials scientists are attentive to strategies being implemented in biochemistry. Research 
in numerous areas is being undertaken to produce materials with biomimicry properties by utilizing 
biological ligands, by which a popular application is in the area of advanced hydrogels. For 
example, a novel hydrogel material was fabricated using a polymer precursor that contains the 
maleimide group. The maleimide served as a dual-purpose functional group, where first it enabled 
the hydrogel fabrication through photochemical cross-linking under UV radiation to yield a 
micropatterned matrix material (Figure 1.7) (Cengiz et al., 2020). Then, the free maleimides in the 
hydrogel served as a bioconjugation tool to functionalize the hydrogel through thiol-Michael 
addition or Diels-Alder cycloadditions reactions (Figure 1.7) (Cengiz et al., 2020).  
 
Figure 1.7. Fabrication and functionalization of hydrogel networks through maleimide 




There are many reactive amino acids in proteins that can be chemically modified such as, 
aspartate, arginine, cysteine, glutamate, histidine, lysine, tyrosine, and the N-terminus of a protein 
(Figure 1.8). Understanding the chemical characteristics of amino acids enables efficient chemo-
selective incorporation of foreign molecules or synthetic probes onto target sites of a native protein 
scaffold affording a functional nanomaterial, through bioconjugation at these amino acid side 
chains. Exploiting this approach is of interest to the current research described in this thesis. 
 
Figure 1.8. Representation of protein side chains subjected to surface conjugation through 
reactive amino acid residues. Image generated by software program Chimera using PDB: 5ERK. 
 
 
1.2.1 Lysine Modification 
The lysine side chain is one of the most frequently modified residues in bioconjugation 
reactions, due to their rich abundance in proteins constituting 5.9% of the sequence of human 
proteins (Matos et al., 2018). The reactive handle of lysine is the ε-amino group, which can be 
efficiently modified with the use of activated esters, isocyanates, isothiocyanates, sulfonyl 
chlorides, along with reductive aminations (Tamura & Hamachi, 2019). To obtain the optimum 
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conjugation yields, lysine modifications are carried out under basic conditions of pH < 8 to allow 
the amine group (pKa = 10) to become deprotonated and thereby nucleophilic. The nucleophilic 
attack by lysine residues will drive the formation of a new bond on the protein (Koniev & Wagner, 
2015).  
Lysine modifications are random under standard conditions which utilize 100-fold or 
greater excess of reagent to the target protein. Heterogeneous products with different degrees of 
modifications are observed, and this strategy is implemented in various major applications. 
However, there exist strategies to produce homogenously lysine-modified products (Nanna et al., 
2017), and other site-selective methods aim for a single-modified amino group, but they usually 
demand an extensive primary sequence engineering or restricting the modification to the N-
terminus of the native protein. A phenomenon has been proposed that in some systems, lysine 
residues exhibit a local pKa variation, so with intentional control of the ambient pH, a lysine 
residue of interest is selected for conjugation. More interesting is a report that employed a 
computational-based study wherein a theoretical reagent (sulfonyl acrylate) could be predicted to 
yield a homogenous product with a single-lysine conjugation under standard conditions using a 
one-molar equivalence of reagent (Matos et al., 2018). This investigation revealed the exclusive 
chemoselectivity towards lysine amino acids and other nucleophilic residues, such as cysteine, if 
present, because of the stable intermediate formed by hydrogen bonding between the lysine amino 
group and the sulfonyl moiety of the reagent (Matos et al., 2018).  
1.2.2 Cysteine Modification  
The side chain of the amino acid cysteine is highly nucleophilic and is relatively low in 
abundance in proteins; existing with a genome-wide percentage of only 2.3% (Tamura & Hamachi, 
2019). The nucleophilic thiol of cysteine can be modified via thiol alkylation (Michael addition) 
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using maleimide or α-halocarbonyl electrophiles. It is important to have well-reduced thiol groups 
by using reducing agents such as dithiothreitol (DTT) or tris-2-carboxyethyl phosphine (TCEP) 
prior to initiating the modification due to the propensity for air oxidation of cystine to its disulfide 
form. It is also important to ensure that these agents are completely removed from the reaction 
mixture to avoid competition with reagents targeted primarily to modify cysteines (Kim et al., 
2008). 
Cysteine targeted modifications are excellent choices for chemoselective bioconjugation 
to afford selective cross-linking. At some conditions, such as the relatively high or low pH range, 
or the presence of a high concentration of thiol-containing nucleophiles around modified cysteine 
residues, the maleimide and the α-halocarbonyl-based reagents could be less efficient 
(Vinogradova et al., 2015). As a result, a number of approaches were developed in the literature 
utilizing transition metal-based reagents that have demonstrated efficiency in cysteine 
modifications and exhibited superior reaction kinetics, where less than five minutes reaction time 
in a pH range varies from 0.4 to 14 was reported to be successful (Messina et al., 2018). More 
importantly, as the aqueous environment is commonly chosen for bioconjugation reactions, a 
judicious choice of the organometallic ligand can afford water solubility (Vinogradova et al., 
2015). 
1.2.3 Polyethylene Glycol Polymers 
Polyethylene glycol (PEG) is a water-soluble polymer chain consisting of repeating units 
of the basic hydrophilic ethylene glycol molecule (-CH2-CH2-O-). The structure is shown in 
(Figure 1.9). PEGs are highly mobile and flexible,  and they have excellent water solubility (Ensing 
et al., 2019). This property is explained by the high density of oxygens, which are the hydrogen 
acceptor atoms. The use of PEG reagents of various free ending molecules has become a leading 
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and an acknowledged approach for the modification of proteins, peptides, or nucleic acid in the 
bioconjugation chemistry field due to the numerous biochemical advantages that PEG can confer. 
This method has been used for decades in bioconjugation reactions and is known as PEGylation.   
 
Figure 1.9. Chemical structure of poly(ethylene glycol) (PEG). 
 
Polyethylene glycol molecules are also used extensively in nanomedicine. The PEG 
conjugated to proteins can reduce immunogenicity and create a molecular shield against proteases. 
In other words, it reduces the protein antigenicity, which refers to the recognition of a foreign 
invader by the immune system (Xiao et al., 2019). A hypothesis suggests that PEGylated proteins 
have more conformational stability, in comparison to the non-PEGylated counterpart. It has been 
suggested that the strength of protein salt-bridges is increased due to the presence of nearby 
conjugated polyethylene glycol (Xiao et al., 2019). More interestingly, different PEG reagents can 
serve as tethers of various short or long lengths to couple between molecules and surfaces to 
produce robust cross-linked materials and cellular sensors (Attwood et al., 2016). 
A study performed by He and colleagues has demonstrated the novelty of PEGylated 
ferritins. Ferritin protein was encapsulated with nanoparticles (NPs) in the interior cavity and 
surface modified at the exterior cavity with PEG spacers of a defined molecular weight and length 
to create a bionanomaterial system of a two-dimensional composite that consists of ferritin-PEG 
molecules separated by controlled distances which were dependent on the length of the PEG 
attachment (He et al., 2013). This strategy was reported to be useful in the design of functional 
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devices requiring incorporated nanoparticles with the advantage of having controllable distances 
between NPs (He et al., 2013).  
PEG modifiers are molecules of immense utility as thousands of literature articles have 
addressed them as typically being the better choice for numerous bioconjugation designs, 
according to a long scientific track record (Hermanson, 1996). The standard conjugation of PEG 
with proteins is achieved by incubating the target protein with a known molar ratio of the PEG 
derivatization reagent in a studied biochemical aqueous environment.  
1.3 Protein Networks  
Among the myriad of bio-building blocks found in nature, proteins possess a phenomenal 
range of structural and functional properties that have allowed them to participate as extremely 
effective molecular constituents to design a wide range of sophisticated biomaterial assemblies. 
Nature has first exploited proteins’ architectural properties to construct bio-networks, by which 
countless examples are naturally manifested, for instance, the bacterial microcompartments 
(BMCs), toroidal oligomerizations, microtubule scaffolds, viral capsids, S-layer protein self-
assembled lattices, and many more (Pieters et al., 2016). These assembled nanomachines perform 
critical roles in bacteria, viruses, and eukaryotic cells. Scientific advancements in understanding 
the highly-ordered assembly mechanisms that lead to structure formation have enabled the current 
creation of novel protein networks, that are utilized by humans for numerous bionanotechnological 
applications. Protein networks are capable of performing versatile functions such as biocatalysis, 




1.3.1 Roles of Protein Networks in Nature  
Bacterial microcompartments are critical proteinaceous organelles produced by bacterial 
cells and essential for the bacterial cell’s metabolism (Figure 1.10) (Yeates et al., 2013). 
Sequentially functional enzymes are evolutionarily encapsulated within the thin protein shell of a 
BMC. For example, the carboxysomes organelles, are BMCs found in cyanobacterium. They 
contain numerous ribulose-bisphosphate carboxylase (RuBisCO) enzymes that capture and 
process carbon dioxide, and carbonic anhydrase (CA) enzymes essential in catalyzing the 
reversible conversion of CO2 and H2O to bicarbonate anions that diffuse into the BMC. Both are 
important in carbon fixation processes and are used to produce energy-rich organic molecules, e.g. 
glucose (Long et al., 2018).   
 
Figure 1.10. A representation of natural three-dimensional supramolecular protein networks. 
Polyhedral bacterial microcompartment (BMC) made of a few thousands BMC shell and vertex 




The S-layer (surface layer) scaffolds are found ubiquitously in life forms as a component 
of several Gram-positive and Gram-negative bacteria, and in all archaeal cell wall envelopes (Sára 
& Sleytr, 2000). These scaffolds have been characterized under the electron microscope as highly 
porous crystalline arrays of a mono-molecular thickness of typically 5-70 nm, and consist of 
proteins or glycoproteins (Gerbino et al., 2015). Their biological role is essential as a protective 
layer from the outer harmful environment including the change in peripheral pH levels (Alp et al., 
2020), protection against mechanical threats, and thermal stabilization especially by the 
glycosylated protein constituents of the scaffold (Klingl, 2014). The importance of protein S-layers 
in bacteria has also been attributed to the removal of toxic metals and radionuclides from the 
polluted sediments and soils by biosorption and bioaccumulation mechanisms (Gerbino et al., 
2015). An illustration of a self-assembled supramolecular S-layer produced by Lysinibacillus. 
sphaericus bacterium is depicted in Figure 1.11 (Baneyx & Matthaei, 2014). 
 
Figure 1.11. An example of naturally occurring protein network. Self-assembled two-
dimensional S-layer protein lattices. Reproduced with permission from (Baneyx & Matthaei, 
2014). 
 
Toroidal oligomers are another interesting category of supramolecular self-assembled 
proteins associated with key roles in cellular processes such as DNA replication and RNA 
transcription of the human genome (Li et al., 2020). They resemble circularly assembled proteins 
wide enough to accommodate DNA strands (Figure 1.12). The ring-shaped protein structure of 
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toroidal proteins was found to function in increasing DNA synthesis processivity by binding to 
DNA polymerase during replication and at the same time encircling the double-stranded chain of 
DNA (Li et al., 2020). The amazing toroidal circular shape is also found in a class of antioxidant 
enzymes called peroxiredoxins. Arrays of cysteine-dependent quaternary-level proteins self-
assemble to create peroxiredoxins that control cellular redox states by scavenging peroxides 
(Yewdall et al., 2018).  
 
Figure 1.12. X-ray structure of a toroidal protein, an example of naturally occurring protein 
network. Generated using Chimera software (PDB: 3P91). 
 
1.3.2 Biotechnological Applications  
The detailed mechanisms by which self-assembly occurs for naturally existing scaffolds 
are yet not fully understood. Nevertheless, the process of self-assembly is driven by the 
thermodynamics of the constituents, and involve a combination of van der Waal forces, dipole-
dipole interactions, the hydrophobic effect, hydrogen bonding, electrostatic interactions, and 
entropic forces. Given current knowledge on protein rational design, scientists are actively 
pursuing the design of protein networks for useful applications in bionanotechnology.  
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Considerable nanotechnological applications of recombinant S-layers were first reported 
in 1986 by Sleytr and Sára, by which the S-layer protein lattices were utilized to produce 
ultrafiltration porous membranes with tailored molecular sieving properties (Sleytr & Sára, 1986). 
Since then, bionanotechnological research has exponentially developed protein networks inspired 
by the bacterial S-layers topology. Immobilized biocatalysts, biotinylated ligand binding, and 
sensing materials for diagnostics, are all functional applications developed from those protein 
fusions (Sleytr et al., 2014). More interestingly, a multilayered protein bio-battery model was 
designed by the use of two types of the self-assembled ferritin protein, Fe(OH)2 iron-loaded and 
Co(OH)3 cobalt loaded ferritins (Watt et al., 2012). The biochemical properties of ferritin proteins, 
in addition to their structural properties, have demonstrated the feasibility of employing this 
building block in the fabrication of nanoscale energy storage systems (Watt et al., 2012). 
Furthermore, the advantages obtained by the complexity and structural diversity afforded by 
protein networks were also exploited to mimic cellular catalytic reactions within synthetic protein 
networks. Previous research has reported on the development of biocatalytic nanomaterials by site-
specific conjugation of enzymes or other catalytic systems onto protein scaffolds (Yokoi et al., 
2011). For example, it was reported that a multienzyme platform consisting of a triple stranded β-
helical fusion protein, dually modified on the surface at lysine and cysteine residues with Re(I) 
and Ru(II) metal complexes respectively (Figure 1.13), resulted in the fabrication of a protein 
scaffold with a robust photoreductase activity that yielded higher CO2 reduction efficiency, in 
comparison to the lower efficiency of a mixture of the individual protein-complexes (Yokoi et al., 
2011).   
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Figure 1.13. Photocatalytic complex constructed by modifying the surface residues of a beta-
helical nanotube using Re(I) and Ru(II) complexes exhibits higher reactivity of the CO2 to CO 
photocatalytic reduction with the multiply-modified construct. Reproduced with permission from 
(Yokoi et al., 2011).           
 Enzyme nanocomposites (ENC) are feasibly developed by self-assembling two 
functionalized nano-dimensional proteins, streptavidin coated with horseradish peroxidase (SA-
HRP) and biotinylated human ferritin capsules (bFNPs), allowing the formation of a tunable sized 
protein network where the biotinylated ferritin plays as the backbone of the material (Figure 1.14) 
for application in ENC-based immunoassays (Men et al., 2015). The size of the overall construct 
is tuned by the control of the bFNPs:SA-HRP stoichiometric ratio, the lower the ratio, the larger 
the assembled construct. The functionality of the ENC was evaluated by using it as a substituent 
to the typical enzyme system employed in a conventional enzyme-linked immunosorbent assay 
(ELISA) assay. The chemical evaluation revealed an improved sensitivity of the immunoassay up 
to 10,000-fold when using the ENC-based method, a signal higher than that of a conventional 
assay due to the larger number of enzymes conjugated to the material (Men et al., 2015). One 
limitation of the streptavidin analogue mediated networks is that achieving uniformity of the 





Figure 1.14. A design of an ENC using ferritin and streptavidin. A) bFNP saturation with SA-
HRP. B & C) Reaction of non-saturated bFNP with SA-HRP drives the formation of dimer, 
trimers, and tetramers. D) A diagram of the full construct of a sensitive ENC material. 

















1.4 Research Hypothesis 
The controlled fabrication of molecular scaffolds to bind with drugs, catalysts, and 
enzymes, among other molecules, is an important area of current research, with applications in the 
areas of medical imaging, therapeutics, biosensors and immobilizations. The current research 
hypothesis is that nanodimensional capsule proteins can be interconnected using the biotin-avidin 
affinity interaction or through the maleimide functional group bioconjugation, to produce 
advanced molecular scaffolds that can be employed to bind and position photocleavable drugs, 
fluorophores, and enzymes onto and perhaps within the network. An illustration of the project full 
scheme is shown in Figure 1.15. These protein networks will be investigated employing a variety 
of techniques including mass spectrometry, electron microscopy, photochemistry, and enzyme 
kinetics.
 
Figure 1.15. An overview of the thesis project scheme that involves the fabrication of protein 
networks and the development of a new bioconjugation strategy.  
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2 Chapter 2: Protein Network Design and Fabrication 
2.1 Background  
2.1.1  Avidin-biotin Interaction 
Avidin is a homotetrameric biotin-binding glycoprotein expressed and deposited in the egg 
whites of several animals, and especially birds. The molecular weight of avidin is 67,000 Da and 
it was shown to have a basic pI of 10.5 (Jain & Cheng, 2017). The X-ray crystallographic structure 
of avidin revealed four identical monomers each of which consists of a 128 amino acid polypeptide 
chain comprising a sequence that is directly involved in the biotin-binding site as shown in Figure 
2.1. Biotin, also known as vitamin H or vitamin B7, is a water-soluble molecule (MW: 244.3 g/mol) 
and is involved in various metabolic processes in living cells. Biotin has been extensively 
associated with polyethylene glycol reagents as (R)x-PEGx-biotin for applications in biotechnology 
and molecular bioassays (Koniev & Wagner, 2015).  
 
Figure 2.1. Crystal structure of tetrameric avidin (PDB: 2AVI) with emphasis on the biotin 
binding site in one subunit. The structure was generated using Chimera employing the protein 
structure code PDB:1AVD. 
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Numerous studies have demonstrated the significance of the “avidin-biotin” affinity 
interaction as a definitive breakthrough (González et al., 1999) (Jain & Cheng, 2017). It was 
determined to be the strongest non-covalent interaction in nature. Avidin’s binding pocket has an 
exceptional specificity and affinity to biotin molecules, as the dissociation constant (Kd) was 
determined to be 10-15 M (Jain & Cheng, 2017). The avidin-biotin complex is resistant to extremes 
of pH values, proteolytic enzymes, and declustering reagents (Hermanson, 1996) (Huberman et 
al., 2001) (Jain & Cheng, 2017). Moreover, the complex is resistant to a temperatures reaching 
117 °C when avidin is fully saturated with biotin (González et al., 1999). The high-affinity 
interaction of biotin and avidin has been exploited in numerous applications in biotechnology such 
as diagnostics, affinity purification, biomolecular labelling, and successful contributions in tissue 
engineering research (Clapper et al., 2008). The strength of the avidin-biotin interaction appears 
in mimicking the strong antibody-antigen interaction; however, it is even stronger by 103 – 106 
times (Jain & Cheng, 2017). Biotins that are bound to the free binding sites of avidin are illustrated 
in yellow (Figure 2.1) residing non-covalently and tightly in the binding pocket of avidin subunits. 
Structural investigations of avidin monomers (PDB: 1AVD) revealed a classic β-barrel composed 
of eight anti-parallel right-handed twisted β-sheets (Figure 2.1) (Strzelczyk et al., 2013), where 
biotin is located at the wide end of the monomeric β-barrel.  
Figure 2.2 is an illustration of the six hydrogen bond interactions that take place at the 
binding site of avidin. Three H-bonds form at the ureido oxygen atom with residues Asn12, Ser16, 
Tyr33, two H-bonds with the ureido nitrogen atom with residues Thr35 and Asn118, and one H-
bond at the sulfur atom with (Thr77) (Huberman et al., 2001). The valeryl carboxyl moiety is also 




Figure 2.2. Biotin molecule representing the six hydrogen bond interactions that take place at the 
binding site of avidin. 
 
As a glycosylated protein, avidin was found to possess a significant carbohydrate 
composition which consists of four to five mannose residues (MW: 180 g/mol) and three N-
acetylglucosamine residues (MW: 221 g/mol) per subunit which constitutes up to 10% of the 
overall protein molecular mass, about 1,383-1,563 Da of carbohydrates in each subunit. The 
oligosaccharide content has no contribution to biotin binding to avidin (Hiller et al., 2015). 
Equally important are two avidin derivatives that have very similar structures to avidin and 
were studied for their exceptional biotin-binding affinity. Streptavidin, a non-glycosylated protein 
isolated from bacterium Streptomyces avidinii, and the protein NeutrAvidin, which is an artificially 
produced deglycosylated form of avidin protein with a lowered isoelectric point (Livnah et al., 




Table 1. Comparison of biotin-binding proteins. 
 Avidin (chicken) Streptavidin (recombinant) NeutrAvidin (avidin) 
Molecular weight 67 kDa 53 kDa 60 kDa 
Biotin-binding sites 4  4 4 
Isoelectric point (pI) 10.5 5 6.3 
Dissociation constant (Kd) 10
-15 M 10-14 M 10-15 M 
Cost per 10 mg $90.00 CAD1 $712.00 CAD1 $277.00 CAD2 
 
1 Bioshop, Canada; 2 ThermoFisher, Canada. Supply issues with Neutravidin were experienced 
 
2.1.2 Cutinase Enzymes for PET Degradation 
The protein cutinase is a hydrolase enzyme found in both bacteria and fungi species. 
Cutinase is secreted to catalyze the hydrolysis of ester bonds found in cutin, the main component 
of the cuticle that covers the surface of plants as a protective layer (Chen et al., 2013).   
 Several studies have begun to examine cutinases as industrial biocatalysts, paricularly for 
their activity towards performing ester hydrolysis that serves the area of waste biodegradation 
(Chen et al., 2013). A recent study has determined that the enzyme cutinase, Humicola insolens 
cutinase (HiC) (Figure 2.3A), was able to display catalytic activity against poly(ethylene 
terephthalate) (PET) consumer plastic, a widely utilized thermoplastic polyester, causing a 
significant plastic degradation when examined under electron microscopy (Carniel et al., 2017). 
The active site of the HiC enzyme employs a serine catalytic triad, and is capable of the 
depolymerization of PET polymers into three compounds (Figure 2.3B, C & D), 
bis(hydroxyethyl)terephthalate (BHET), monohydroxyethyl terephthalate (MHET), and 




Figure 2.3. A) Ribbon representation of HiC enzyme (PDB: 4OYY). The chemical structure of 
PET degradation products: B) BHET, C) MHET, and D) TPA. 
 
2.1.3 Photocleavable Biomaterials   
Photocleavable agents are molecules serving as a bioconjugation reagent that links between 
two molecules and which can undergo decomposition of their molecular structures upon irradiation 
with light, generally ultra-violet light being employed for this purpose (Gomes & Gozzo, 2010). 
The functional groups of the photocleavable cross-linkers employed in the fabrication of photolytic 
materials can contain functional groups such as carbamate, carbonate, ester, or amide moieties. 
Particularly, photolabile cross-linking moieties follow any of the following classes; nitrobenzyls 
(NB), coumarins, disulfides, azo sulfonates, pyrene esters, metal-metal bonds, and vinyl ketones 
(Pasparakis et al., 2012), which possess variations in terms of their cleavage behavior. These 
materials are studied especially for their potential applications in the fields of tissue engineering, 
controlled drug delivery, therapeutics, biosensing, waste management, and food science (Levalley 
et al., 2020). A study of a photo-triggered drug release from a hydrogel material was researched 







a photocleavable linker with a dicoumarin moiety via an ester bond into a methyl methacrylate 
polymer-based hydrogel. The findings presented a successful release of the drug from the hydrogel 
system upon UV irradiation (Härtner et al., 2007). 
Concurrently, the heterobifunctional PEG-based 3D hydrogel materials with nitrobenzyl 
moieties are one of the most studied 3D networks in tissue engineering (Ji et al., 2017). These 
photodegradable hydrogel systems exhibit marked photolytic response under physiological pH, 
making them a perfect choice for the design of a biocompatible and tunable protein-based scaffold.  
2.2 Objectives 
In this part of the project, the objective is to show how to engineer a novel supramolecular 
protein scaffold using biotinylated multimeric ferritin capsule proteins, as a building block along 
with the protein avidin as a tetravalent mediator (Figure 2.4). The biotin-avidin non-covalent 
interaction is exploited in this context to facilitate the proximity of the capsule proteins to self-
assemble the protein network. Use of the biotin-avidin affinity interaction is a strategic choice, as 
it resembles a highly specific interaction since it will occur independently of the protein’s physical 
characteristics, e.g. hydrophobicity, or its chemical characteristics, e.g. surface charge, of the 




Figure 2.4. An illustration of a supramolecular protein scaffold assembled from biotinylated 
ferritin and avidin proteins. 
 
The model capsule proteins will be chemically labelled with a diverse set of biotin-PEG 
reagents. The polyethylene glycol cross-linkers with biotin at one end will be installed on the outer 
surface of the protein horse spleen ferritin to act as a tether to link proteins into a scaffold-like 
material. This approach is pursued using a selection of PEG reagents with electrophilic leaving 
groups such as, NHS and TFP activated esters, which interact with the nucleophilic amino acid 
residues located on the protein surface to form a covalent amide bond. Additionally, PEG as a 
component to the cross-linking agents has been chosen for this project, instead of alkane-based 
cross-linkers, because it is water-soluble. The proteins of interest are soluble in aqueous buffer 
solutions, therefore PEG appeared to be the most reasonable and compatible choice.  
The choice of avidin as the biotin-binding component was also considered from the point 
of view of commercial availability in sufficient quantities and expense, as well as the additional 
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presence of carbohydrate attachments. The presence of the carbohydrate component on avidin 
compared to its absence on other biotin-binding proteins, was considered as a potentially useful 
moiety since carbohydrate-binding proteins, termed lectins, might also bind to exposed 
carbohydrate residues on the protein network. This might allow for lectins labelled with a variety 
of molecules such as fluorophores, to bind to these protein networks, extending the sophistication 
of these biomaterials. 
More importantly, we aim to show the versatility of the fabricated protein network in 
various applications. As illustrated (Figure 2.5), hundreds of potential conjugation choices and 
approaches could be pursued to provide novelty to this biomaterial. This chapter elaborates on the 
methodical design of a ferritin-avidin network reinforced with enzymatic, photocleavable, and 
magnetic functionalities.   
 
Figure 2.5. A broad design strategy. A wide range of capsule proteins, linker chains/proteins to 





The following compounds were obtained from the noted commercial sources: Horse spleen 
ferritin was obtained from Sigma-Aldrich (Oakville, Canada). biotin-dPEG®12-TFP ester, biotin-
dPEG®24-TFP ester, biotin- TFP-PEG4-Lys (PEG4-biotin)2, biotin-dPEG
®
11-MAL, were obtained 
from Quanta BioDesign, Ltd. (Plain City, Ohio, USA). PC Biotin-PEG3-NHS carbonate ester was 
purchased from BroadPharm (San Diego, CA, USA). PEG 2K and 5K were purchased from 
Creative PEG Works (Durham, NC, USA). Avidin was purchased from Bioshop Canada Inc. 
(Burlington, Ontario, Canada). Streptavidin was purchased from Cedarlane (Burlington, Ontario, 
Canada). Neutravidin was purchased from Thermo Fisher Scientific (Mississauga, Ontario, 
Canada). HiC was purchased from Alfa Aesar (Haverhill, Massachusetts, USA). Bovine serum 
albumin (BSA) was purchased from Bioshop Canada, Inc. Tween 20 was purchased from Sigma-
Aldrich. Poly(ethylene terephthalate) film was purchased from Goodfellow, distributed by Delta 
Scientific. The poly(ethylene terephthalate) film purchased corresponded to the product number 
ES301445 and is a 0.25 mm-thick, 300x300 mm sheet of transparent, amorphous material. 
BeaverBeads Mag COOH were kindly supplied by GeneBiosystems, Inc. (Oakville, Ontario, 
Canada). EDC and NHS-biotin-dPEG®3-NH3
+TFA- were purchased from Quanta BioDesign, Ltd. 








2.4 Methodology  
2.4.1 Mass Spectrometry 
2.4.1.1 ESI MS 
The masses of the protein samples were determined using a soft ionization technique that 
employs a Thermo ScientificTM Q-Exactive Hybrid Quadrupole-Orbitrap (Waltham, MA, USA) 
mass spectrometer with an Electrospray Ionization Source (ESI). The protein samples to be 
analyzed were desalted by exchange with doubly distilled water (DDH2O) using Amicon® Ultra 
Centrifugal Filters with a 10 kDa molecular weight cut-off (MWCO) for 4-5 centrifugation rounds 
at 6720 g (small benchtop lab centrifuge) to remove buffer salts, excess labelling reagent, or 
impurities and then were diluted to a final volume of 50 µL and a concentration of 1-10 pmol/µL 
using a mobile solvent mixture of 50:50 MeOH/H2O:0.1% formic acid. The prepared sample was 
injected in the instrument at a flow rate of 10 µL/min in the positive mode (+ESI) through a metal 
capillary, where heat (300 °C) and high voltage (2.5-3.2 kV) are applied to assist the ionization 
process. Under the effect of the electric field, a droplet is formed at the exit of the capillary, which 
gradually sprayed into a mist of smaller charged droplets. Then the small droplets evaporate to 
generate gas-phase ion species. The ion species travel through the quadrupole mass filter that filters 
the uncharged neutral species, then the ion species fly to the orbitrap for mass to charge (m/z) ratio 
detection (Michalski et al., 2011). Mass to charge ion peaks were deconvoluted to resemble their 




2.4.1.2 MALDI-TOF MS 
Protein samples were analyzed using the matrix assisted laser desorption ionization-time 
of flight (MALDI-TOF) technique using a Bruker Autoflex Speed instrument for molecular mass 
detection. Samples to be analyzed were desalted prior to analysis using Amicon® Ultra Centrifugal 
Filters, following a purification protocol similar to the one used for ESI-MS samples. Protein 
samples were diluted with DDH2O to a final concentration of 10 μM. Sample preparation was 
performed using the dried droplet method with a sample:matrix ratio of 1:1, by which a mixture 
of 1 μL of the purified protein sample with 1 μL of the sinapinic acid solution was made and 
pipetted onto a metal plate until it dried forming a crystalline droplet. The metal plate containing 
the sample was subsequently loaded into the MS instrument. The choice of using sinapinic acid 
was made as it was proven to be compatible with proteins in the 10-150 kDa mass range. Using 
sinapinic acid in this method is important as it is a matrix compound capable of protecting the 
sample from being destroyed by the UV-laser beam, while working as a laser energy-absorbent 
and proton source, making it essential to soft-ionize the protein sample, in addition to facilitating 
the vaporization of the sample (Clark et al., 2013). The mass spectrometer was calibrated with a 
protein standard consisting of: Alpha Lactalbumin (14,177 Da), Soybean Trypsin Inhibitor (19,977 
Da), Trypsinogen (23,982 Da) and Carbonic Anhydrase (29,024 Da). 
2.4.2 Ultraviolet-Visible (UV-Vis) Absorbance Measurements  
The UV-Vis spectrophotometric absorbance measurements were carried out using the 
SpectraMax 5 microplate reader from (Molecular Devices, Sunnyvale, CA, USA) equipped with 
SoftMax® Pro Enterprise software. The solutions were placed in a Quartz Cuvette (1 cm 
pathlength, 1.5 mL volume).  
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2.4.3 Biotinylation of HSF Protein Through Lysine Modification 
Horse spleen ferritin (55 mg/ml, 90.9 µL) in 150 mM saline solution was purchased from 
Sigma-Aldrich. The concentration of the protein stock solution was confirmed by the Bradford 
and Lowry assays (Lu et al., 2010). The commercially available reagents biotin-PEG4-NHS ester, 
biotin-PEG12-TFP ester, biotin-PEG24-TFP ester, and biotin-bifurcated PEG4-TFP ester (Figure 
2.6) were obtained from Quanta BioDesign, Ltd. to target the lysine residues on HSF. The reaction 
was performed in potassium phosphate (KP) buffer, 150 mM, at pH 7.4. This potassium phosphate 
buffer was prepared using 8 g of KH2PO4 and 16 g of K2HPO4 diluted in 100 mL DDH2O, pH 7.4. 
The pH was adjusted using NaOH or HCl when necessary.   
 The HSF protein was dissolved in the 150 mM KP buffer with a final HSF concentration 
of 10 mg/ml as recommended by Hermanson (Hermanson, 1996). The biotinylation powder 
reagent was weighed using an analytical balance and immediately added to the reaction vial. The 
molar excess of the reagent to capsule was (capsule:reagent, 1:150-200 molar equiv.). The vial 
was vortexed carefully, then was incubated either for 1 hour at room temperature or overnight at 
4 °C to allow the reaction to proceed. After the incubation time had elapsed, the mixture had 
undergone 4-5 rounds of washing with DDH2O using a centrifugation-based size exclusion filter 
(Amicon® Ultra) with a (MWCO) of ~10,000 Da in an Eppendorf Minispin centrifuge at 6720 x g 
to subsequently remove the unconjugated biotin reagent, the buffer components, and the by-
product tetrafluorophenol, resulting in only biotinylated ferritin ready for mass analysis. MALDI-
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TOF in positive-ion linear mode was employed to determine the mass of the biotinylated 
monomeric HSF subunits and the degree of modification. 
 
Figure 2.6. Biotinylation reagents. A) the chemical structure of Biotin-PEG(n)-NHS ester. B) the 
chemical structure of Biotin-PEG(n)-TFP ester. C) Trifunctional PEG “TFP-PEG4-Lys (PEG4-
biotin)2”. 
 
 Two additional reagents, biotin-PEG2K-NHS ester and biotin-PEG5K-NHS ester were 
purchased from Creative PEG Works (Durham, NC, USA), were also studied for conjugation with 
the HSF protein, following the same mentioned procedure. However, a wider range of molar 
excesses was utilized in these reactions. For the PEG5K spacer arm, 1:72, 1:100, 1:300, 1:360, 
1:380, 1:800 molar excess of the commercial reagent was employed in the bioconjugation reaction. 
Furthermore, for the PEG2K, 1:200, and 1:3000 molar excess was used. Additionally, a time-point 
aliquot procedure was performed using the PEG 2K, where the reaction started with 1:150-fold 
excess and then an additional 150-fold excess was added after every 1 hour time-point for 5 hours, 
summing up to a total 750-fold at the end point. After each 1-hour cycle, an aliquot was pipetted 
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out, desalted using Amicon® Ultra filters, and taken to analysis using MALDI-TOF mass 
spectrometry.    
 The experiment which contained 1:3000-fold excess of PEG2K used 2 mg/ml of HSF 
protein, instead of 10 mg/ml. The reaction was conducted in a 100 mM KP buffer at pH 7.0 
following a previously reported procedure (Shukla et al., 2013). 
2.4.4 Lysine Modification Using a Photocleavable Linker 
 The HSF protein (55 mg/ml, 90.9 μL) in saline solution was mixed at 23 ºC with the 150 
mM KP buffer solution and made up to 500 μL with distilled water, making the final concentration 
of ferritin to be 10 mg/ml. This solution was then added to a 1.9 mg (218-molar equiv.) of the 
nitrobenzyl-based photolabile biotinylation reagent, PC biotin-PEG3-NHS carbonate ester (Figure 
2.7), in a centrifuge tube. The tube was incubated at room temperature for 1 hour, then desalted to 
remove buffer and unlinked reagent molecules using Amicon® Ultra filtration device for 5 rounds 
at 6720 x g.  
 
Figure 2.7. Chemical structure of PC Biotin-PEG3-NHS carbonate ester. 
 
2.4.5 Cysteine Modification of HSF Protein 
Horse spleen ferritin (55 mg/ml) was conjugated with the commercial maleimide-based 
reagent Biotin-dPEG®11-MAL (Figure 2.8) (2 mg resulting in a 210-fold molar excess) in 150 mM 
KP buffer solution at pH 7.4. A final 10 mg/ml concentration of HSF was employed. The reaction 
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was incubated at room temperature for 1 hour then purified using the Amicon® Ultra filtration 
device for 5 consecutive rounds against DDH2O at 6720 x g to remove the unconjugated reagent 
and the buffer solution. The sample was analyzed with MALDI-TOF in positive-ion linear mode. 
 
Figure 2.8. The chemical structure of the biotinylation reagent Biotin-PEG11-MAL. 
 
2.4.6 Bioconjugation of Magnetic Beads  
2.4.6.1 Magnetic Beads Surface Carboxyl Activation 
BeaverBeads Mag COOH (300 nm diameter) were kindly supplied by GeneBio Systems, 
Inc. The magnetic beads surface, which displayed carboxyl groups, had undergone carboxyl 
activation to achieve biotin reagent coupling. An aliquot (100 µL, 10 mg/ml) was pipetted into a 
centrifuge tube, gently blended, then separated from the preservation solution (20% ethanol). A 
magnetic separator was used to facilitate the separation of the supernatant from the magnetic 
particles. A solution of 2-ethanesulfonic acid (MES) buffer (200 µL, 100 mM, pH 5.0) was used 
to wash the magnetic beads twice, and 0.05% Tween 20 detergent was added to the buffer to 
improve the bead’s dispersity. The wash supernatant was removed from the aliquot. Freshly made 
10 mg/ml solutions of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-
hydroxysuccinimide (NHS) were prepared with the 2-ethanesulfonic acid containing 0.05% 
Tween 20 (MEST) buffer. A 100 µL of each, EDC then NHS solutions, were added to the magnetic 
beads to activate the surface carboxyl groups. Next, the magnetic beads were incubated for 30 
minutes at room temperature.  
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2.4.6.2 Covalent Coupling of Magnetic Beads with Biotin 
 A 50 µL aliquot of the activated magnetic beads solution was used in this step. The 
solutions of EDC and NHS were discarded from the aliquot then the biotin coupling reagent, 
Biotin-PEG3-NH3
+TFA- (200 µL, 178 equiv.), in a phosphate-buffered saline (PBS) solution at pH 
8.0 with 0.05% Tween 20 (PBST) was added to the beads. The reaction was incubated for 2 hours 
at room temperature. The 200 µL supernatant that contained the biotin reagent was separated from 
the beads by magnetic separation using a bar magnet held to the surface of the glass tube. A 200 
µL solution of PBST buffer at pH 7.2 with 1% w/v glycine was added to the beads to react with 
any activated but uncoupled carboxyl groups. The solution was incubated for 1 hour at room 
temperature. The solution containing glycine was separated from the magnetic beads as described 
previously using a bar magnet. Then the beads were washed using PBS buffer for three times and 
preserved in 200 µL of PBS at 4 °C. The bioconjugation scheme is shown in (Scheme 2.1). 
 
Scheme 2.1. The mechanism of carboxyl groups activation and biotinylation of magnetic beads. 
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2.4.6.3 Biotin-4-Fluorescein Quantification Assay  
 The assay was conducted in 1X PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM 
NaCl, 2.7 mM KCl) at pH 7.4. A stock solution of biotin-4-flourescein (B4F) (Figure 2.9) was 
prepared with a concentration of 16.8 µM with protection from light. The absorbance and 
concentration were measured using a UV-Vis spectrophotometer at 495 nm and an extinction 
coefficient of 68,000 M-1 cm-1. A calibration curve was created to convert the fluorescence data to 
molar values over the range of 0-730 nM of B4F in PBS buffer.  
 
Figure 2.9. Structure of biotin-4-fluorescein (B4F). 
 
The B4F solution was diluted with PBS buffer to 400 nM and pipetted into a quartz cuvette 
to measure the fluorescence at 490 nm excitation and 525 nm emission with a 515 nm cut-off. A 
solution of the biotin-binding protein, streptavidin, was prepared with a concentration of 100 nM 
and added to the B4F to quench the fluorescein intensity. Then, a sample containing 400 nM biotin 
on magnetic beads was added to the B4F/streptavidin solution in the cuvette to monitor the 
displacement of B4F by biotin on the beads.  
2.4.7 Protein Network Formation 
A set of experiments was conducted to study the protein network formation using three 
different biotin-binding scaffold mediating proteins (Table 2). The following biotin-binding 
43 
 
proteins; the avidin (Av), streptavidin (SA), and neutravidin (NA), were tested with the 
biotinylated ferritin capsule. The biotinylated ferritin used in these experiments was cross-linked 
with Biotin-PEG24-TFP attachment. The concentrations used in these experiments were the 
following, [Av] = 29.25 mg/ml, [SA] = 23.75 mg/ml, [NA] = 29.25 mg/ml, [BF] = 10.37 mg/ml. 
The total volume of all the reaction mixtures in each experiment was set to 48.2 µL. Moreover, 
two experiments were carried out to test the protein network formation in higher ionic strength 
solutions of 0.3 M and 1 M of sodium chloride (NaCl) salt. All the networks in Exp #1-5 (Table 
2) were allowed to assemble in a glass vial while incubated at room temperature and the formation 
was monitored over a time duration up to 7 days.  
 Table 2. Experimental setup for protein networks. 
 
 
Av*: Avidin analogue (streptavidin or neutravidin) 
2.4.8 SEM Characterization  
Samples of biotinylated ferritin produced by reaction of ferritin with biotin-PEG24-TFP, 
followed by interaction with avidin were prepared on pre-ultrasonicated silicon chips with 
methanol and isopropanol. The Zeiss Merlin® Scanning Electron Microscopy (SEM) instrument 
was employed in the characterization of the samples with a beam accelerating voltage of 10 kV. 
Exp # Av or Av* (µL) NaCl (µL) BF (µL) H2O (µL) Total volume (µL) 
1 Av: 28.2 0 10 10 48.2 
2 Av: 28.2 10 [0.3 M] 10 0 48.2 
3 Av: 28.2 10 [1 M] 10 0 48.2 
4 SA: 22.9 0 10 14.3 48.2 
5 NA: 22.46 0 10 15.74 48.2 
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2.4.9 Suspension of Biotinylated HiC Enzymes within the Ferritin-avidin Scaffold 
 Horse spleen ferritin protein (10 mg/ml) was cross-linked with TFP-PEG24-biotin (190-
fold molar excess) reagent in a 100 mM KP buffer at pH 7.4 and was incubated for 1 hour at room 
temperature to produce biotinylated ferritin, which afterward was confirmed with MALDI-MS. 
This product was combined with the protein avidin to create the supramolecular ferritin-avidin 
scaffold. Specifically, the assembly of the protein scaffold was conducted by incubating 50 mg/ml 
biotinylated ferritin solution with 50 mg/ml avidin solution in a 1:18 molar ratio, then allowing the 
mixture to self-assemble at room temperature for two hours. After two hours, the scaffold was 
washed with DDH2O to eliminate the excess unbound avidin, then an additional round of washing 
was performed with 100 mM KP buffer, 150 mM NaCl, and 0.1 – 1% w/v bovine serum albumin 
(BSA) solution at pH 7.2. To ensure that all the unbound avidin was eliminated, the rinsed wash 
solution was measured using a UV-Vis spectrometer at 280 nm, where multiple washes were 
performed until the absorbance measures were detected at the background level indicating no UV 
absorbance to confirm the removal of the excess protein. The final scaffold was transferred to a 
new polypropylene centrifuge tube. 
Later, the biotinylated HiC enzyme solution was introduced to the protein scaffold and 
incubated for 30 minutes at room temperature. Again, the mixture was washed with 100 mM 
sodium phosphate, 150 mM sodium chloride, 0.1% w/v BSA, and 0.05% v/v Tween 20 in order to 
rinse out any unbound biotinylated enzyme before starting an enzymatic assay to test the activity 
of the scaffold. While rinsing the unbound biotinylated enzyme from the scaffold solution in the 
polypropylene tubes, the assembled material was centrifuged between the washes at 6720 x g for 
10 minutes to minimize the chances of material loss while pipetting during the wash steps. After 
washing, the final scaffold was transferred to a new polypropylene centrifuge tube. Ultimately, an 
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enzyme activity assay was conducted on the enzymatic ferritin-avidin scaffold with the p-NPB 
substrate, by which the substrate hydrolysis by the enzymatic scaffold was determined according 
to the UV absorbance measurements at 347 nm, described in detail in Jameson Pfeffer’s M.Sc. 
thesis (Pfeffer, 2019), a former member of the Honek laboratory who provided the biotinylated 
HiC enzyme for these sets of experiments. 
2.4.10 Enzymatic Scaffold-PET Sample Preparation for Degradation Studies 
As a control sample, poly(ethylene terephthalate)-Glass Fiber (PET-GF) was cut into small 
sections of 1×1 cm and placed in 1.5 mL centrifuge tubes filled with 1.5 mL of 200 mM sodium 
phosphate buffer at pH 7.0. The buffer solution contained about 20 mg/ml of the HiC enzyme. The 
tube cap was tightly sealed using a piece of Parafilm to avoid solvent evaporation. The PET-
enzymatic scaffold was incubated at room temperature or 55 °C to react over the next 15 days. 
After day 15, the PET sections were cleared with Tween 20 solution (0.1% v/v) then washed with 
DDH2O.  
In the enzymatic scaffold experiment, the effect of the bound enzyme was examined on 
PET. In this experiment, a small-sized petri dish was used as a container. A droplet of the scaffold 
in buffer solution was mounted on a PET section, then directly was placed in a petri dish. A 1 mL 
volume of buffer was pipetted as small droplets in the inner circumference of the dish to provide 
a humid surrounding environment for the scaffold, then the petri dish was covered. The storing 
conditions and the cleaning procedure implemented on this scaffold were the same as followed in 
the control experiment mentioned above.  
Characterization of the PET sections designed above after 15 days incubation period was 
performed in the WATLAB using a scanning electron microscope (SEM) FEI Quanta FEG 250 
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with a 20 kV voltage setting. These experiments were accomplished collaboratively between Mr. 
Pfeffer and myself, where I provided the protein networks and performed the incubations and the 
results were discussed jointly. 
2.4.11 The Assembly of a Photocleavable Protein Network 
Biotinylated ferritin produced as a result of the reaction with the photocleavable linker, PC 
biotin-PEG3-NHS carbonate ester, that yielded the conjugation of one biotin molecule attachment 
on each HSF subunit, was added directly (50 mg/ml) to freshly reconstituted avidin protein 
solution (50 mg/ml) using a molar ratio of 1:21 (ferritin:avidin) in a new glass vial. Additionally, 
a control experiment utilizing an unbiotinylated ferritin solution mixed with avidin was performed 
for comparison. The mixture was set at room temperature for further experimentation. These 
experiments were performed under my direction and in collaboration with a Chem494 exchange 
student, Thomas Daniel. 
2.4.12 Photolysis of the Protein Network  
Three samples (each 5 μL) volumes were pipetted from the prepared protein network and 
placed into separate wells in a polystyrene microplate. A handheld UV radiation device with a 
wavelength at 365 nm, 6 W output was utilized to perform the network photolysis at three different 
time points. The three samples had the following labels; a control, 30 min, and 45 min, to assign 
the time duration of UV light exposure. Later, the sample masses were determined using MALDI-





2.5 Results and Discussion  
2.5.1 Lysine Modification on HSF Protein  
The conjugation of PEG with proteins to achieve lysine modification through the formation 
of a covalent amide bond with the activated ester reagent, is termed an acylation reaction. The 
reaction is achieved by incubating the target protein with a known molar ratio of the PEG 
derivative reagent that contains the reactive ester moiety, in a studied biochemical aqueous 
environment. Several heterobifunctional cross-linking reagents were utilized for the modification 
of lysine residues on HSF. The biotinylation reactions of ferritin with the set of biotin-PEGn-TFP 
reagents were originally prepared in a KP buffer at pH 7.4. The pKa of the ε-amino group of lysine 
residues is 10.5. Reaching a pH value of 10.5 or above in the conjugation reaction to fully 
deprotonate the ε-amino groups of lysine residues would risk the complete hydrolysis of the 
activated ester of the biotinylation reagent in the aqueous solution producing a non-reactive 
reagent. To slow the rate of the ester hydrolysis and at the same time produce a nucleophilic lysine 
residue, it is recommended that employing a suitable buffer in the range of pH 7-9 can maintain a 
pH that will establish partially deprotonated lysine ε-residues on a ferritin capsule that are 
nucleophilic enough to undergo the alkylation reaction (Hermanson, 1996). After preliminary 
purification of the biotinylated ferritin using an Amicon centrifugal filter, the samples were 
analyzed by MALDI-TOF MS. Modified protein samples were diluted to a final concentration of 
~10 μM and prepared for MALDI analysis using the dried droplet method, by which 1 μL of the 
purified protein sample was added to 1 μL of the sinapinic acid matrix and pipetted onto a plate 
until it dried and then was subsequently loaded into the instrument. The following paragraphs will 
describe the mass spectrometry result analysis of the protein conjugation. 
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MALDI-TOF MS was employed to analyze the HSF-conjugate masses, as this protein 
particularly, as for many glycosylated proteins, was challenging to analyze using the ESI technique 
due to the occurrence of ion suppression (Annesley, 2003).  A close look at the literature reveals a 
lack in utilizing the ESI-MS approach to characterize horse spleen ferritin. Only a few reports in 
literature have demonstrated the use of MS on horse spleen ferritins, utilizing the MALDI-TOF 
MS technique (Lan & Zenobi, 2019) (Zeng et al., 2008).  
The first spectrum, Figure 2.10A, is a control sample that shows a mass peak at 20005 m/z 
that corresponds to an unmodified monomeric HSF subunit. Spectrum B (Figure 2.10B) represents 
a ferritin subunit biotinylated by utilizing a 136-fold molar excess of biotin-PEG12-TFP reagent. 
In spectrum B, two more significant mass peaks were detected and not found in the control. The 
second detected mass peak is at 20780 m/z, with an increment in the mass of approximately 806 
m/z. This increase is consistent with the attachment of one biotin-PEG12 (850 Da) molecule to each 
subunit. The third mass peak (Figure 2.10B) corresponds to two biotin-PEG12 attachments per 
ferritin subunit, but in lower intensity compared to the second mass.  
As regards to the HSF reaction with the biotin-PEG24-TFP ester reagent, spectrum B 
belongs to a ferritin subunit conjugated by utilizing a (150-200) molar excess of the biotin-PEG24-
TFP reagent. A peak corresponding to 19999 Da was observed, in addition to a substantial peak at 
21345 m/z (spectrum B). The peak at 21345 m/z is consistent with one biotin-PEG24 molecule 
attached per subunit, by which the molecular weight of one biotin-PEG24 attachment is 1378 Da. 
This chromatogram reveals a mixture of unmodified and mono-modified monomeric HSF 
subunits, in the reaction mixture. This result reveals an approximate overall average of 50%:50% 
labelling in each ferritin capsule.  
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With respect to Figure 2.10D, the mass spectrum exhibits a mass analysis of ferritin 
conjugated with the trifunctional PEG reagent, biotin-bifurcated PEG4-TFP (TFP-PEG4-Lys 
(PEG4-biotin)2). The spectrum represents a low-intensity peak of subunits conjugated with one 
biotin molecule. 
 
Figure 2.10. MALDI-TOF result of biotinylated ferritin subunits. A) a control spectrum shows a 
peak of one unmodified ferritin subunit. B) A modified ferritin subunit with biotin-PEG12-TFP 
exhibits a control peak in addition to a second peak indicates one modification. C) Ferritin 















The reagent with the PEG4 linker has a fully extended maximum length of 1.92 nm, the 
PEG12 linker has a maximum length of 4.75 nm and the PEG24 linker has a maximum length of 
9.9 nm (Quanta BioDesign). These nano-sized spacer arms play a key role in determining the 
spatial dimensions of the protein scaffold material, by which they extend the distance between the 
biotin molecule and the end of the conjugated amino acid (e.g. lysine) on the modified ferritin that 
will work as the building block. 
Moving on to extend the protein network design, we chose to explore even longer spacer 
arms, so biotinylation reagents with longer PEG chains were studied. Biotin-PEGn-NHS ester 
derivatives with molecular weights of 2000 Da and 5000 Da have approximately 45 and 113 
ethylene glycol units in the chain, and a maximum arm length of 18.5 nm and 46.6 nm, respectively 
(Quanta BioDesign). A broad set of experiments utilizing different protein:reagent molar ratios 
were conducted in this project. Using PEG2K spacer arm, the set of 1:150, 1:200, and 1:3000, and 
using PEG5K spacer arm, the set of 1:72, 1:100, 1:300, 1:360, 1:380, 1:800 stoichiometric ratios 
were all attempted. In this work, the standard modification procedure was followed, in addition to 
several previously reported procedures that had adjusted minor conditions such as; incubation 
period and pH levels, were implemented as well. The resulting modifications were monitored using 
MALDI-TOF MS. All these procedures were found to be unsuccessful in the current research; 
wherein no modification was observed on the HSF protein subunits (data not shown). It is worth 
mentioning that during some of these experimental runs, an apparent protein precipitate was 
observed in the reaction vial.  
However, one bioconjugation reaction among all the above-mentioned experiments was 
observed to show a clear, yet not significant modification. Those experiments employed the 
PEG5K reagent. The MS results for the bioconjugation utilizing the biotin-PEG5K-NHS ester 
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reagent with HSF protein are shown in Figure 2.11. Figure 2.11A is the spectrum of the control 
mass of unmodified ferritin. Two ferritin aliquots were each incubated with an 800-fold molar 
excess of the reagent for 1 hour at room temperature and for 24 hours at 4 °C, respectively. The 
mass spectrometry data from both samples (Figure 2.11B & C) exhibit low-intensity mass peaks 
at 25301 m/z and 25398 m/z indicating a low labelling yield, in contrast to the substantial yields 
of the reactions performed using shorter PEG linkers. Generally, the peak heights in mass 
spectrometry, unless a standard curve is made, should not indicate quantitative information 
because different compounds ionize differently in the MS, although very related structures may 
indeed ionize in a similar fashion and to a similar extent, like the ferritins were are analyzing here. 
It is suspected that the length of the PEG spacer structure linking the chemical moiety to 
the protein target has an effect on the overall labelling yield. Perhaps the 2000 and 5000 Da 
molecules may have contributed a steric hindering effect that limited the NHS moiety’s approach 
the reaction site.  
NHS-ester reagents are the most commonly used reagents in bioconjugation reactions due 
to the well-established methods developed, and due to the broad commercial availability of various 
NHS-containing reagents (Hermanson, 1996). However, the NHS ester does hydrolyze rapidly in 
the aqueous solution during the bioconjugation reaction, which demands a very high excess of the 
reagent to obtain the desired degree of modification. On the other hand, TFP ester-based reagents 
exhibit longer half-lives in solution, which implies that TFP possesses a higher hydrolytic stability 
in comparison to the NHS ester (Lockett et al., 2008). Previous experiments carried out in the 
laboratory have shown that increased biotinylation levels can be obtained with TFP reagents, 
greater than those obtained by using NHS reagents, despite the use of a higher excess of NHS 




Figure 2.11. MALDI spectra of ferritin subunits cross-linked with biotin-PEG-NHS ester 
(MW=5000 Da). A) Ferritin control (not biotinylated). B) Biotinylation with 800-fold reagent at 
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2.5.2 Cysteine modification on HSF protein 
Covalent cysteine-targeted modifications of proteins are common as well in the bioconjugate 
chemistry. In this section, thiol-cysteine modification experiments on HSF with a biotinylation 
reagent are discussed. The surface of the HSF capsule was bioconjugated with a biotin-PEG11-
MAL reagent, following the standard bioconjugation process using a 210-fold molar excess of the 
biotin reagent. Afterwards, the sample was buffer exchanged with DDH2O using 10 kDa MWCO 
Amicon® Ultra centrifugal filters, then submitted to MS analysis. Analysis of the MALDI-TOF 
data showed no mass peak evidence of HSF cysteine bioconjugation with the biotin-PEG11-MAL 
attachment (data not shown). Screening literature articles on possible cysteine surface 
modifications on ferritins revealed no recorded success for cysteine modification on a ferritin 
protein. According to the amino acid sequence of horse spleen ferritin (PDB: 5ERK), ferritin has 
one cysteine residue per subunit. It is common knowledge that successful chemical modifications 
occur on a surface exposed residue rather than internally buried amino acid residues. Therefore, in 
order to investigate the exact position of cysteine in the HSF quaternary structure and its level of 
exposure on the outer curvature of the capsule, the protein structure was modeled using UCSF 
Chimera software, employing the protein structure PDB: 5ERK (Goddard et al., 2005). Figure 2.12 
presents the surface of HSF with three adjacent subunits highlighted. The model shows the cysteine 
residue in yellow clearly buried close to the intermolecular grooves of the capsule. The model 
supports the limited susceptibility for cysteine modification on HSF and the restricted tendency 
for the reagent to approach and modify the cysteine. This experiment is of importance for the 




Figure 2.12. Space-filled model of the horse spleen ferritin protein (PDB: 5ERK). The model 
shows one cysteine residue (yellow) in each subunit located in a buried position in the 






2.5.3 Biotinylated Magnetic Beads 
2.5.3.1 Energy-Dispersive X-ray Spectroscopy 
Studies on attaching magnetic beads to the protein networks were investigated in a 
preliminary manner in order to eventually be able to use magnetic fields to recover catalytic protein 
networks for reuse. The carboxyl groups on the magnetic bead’s surface were activated and 
coupled with a biotin reagent. Since magnetic beads cannot be characterizable using any of the 
previously employed mass spectrometry techniques, a different analytical technique was pursued. 
Energy-Dispersive X-ray Spectroscopy (EDX) was used as a qualitative tool to characterize the 
chemical or elemental composition of the beads. Since these magnetic particles are made of an 
agarose polysaccharide shell and filled with iron (III) oxide in the core, it was expected that a 
signal for the elements C, H, N, and Fe would be detectable.   
 The result of EDX elemental analysis for a control sample of unbiotinylated magnetic 
beads is shown in Table 3. The elemental composition consisted of a considerable percentage of 
carbon (C), and oxygen (O), which makes up the agarose polysaccharide shell, and most 
importantly iron (Fe), which fills the core of the beads in the form of iron (III) oxide, Fe3O4. 
Moreover, the silicon (Si) composition indicated in the table is referred to as the silicon chip that 
was used to carry the sample on the sample holder. Table 4 shows the elemental profile of the 
biotinylated magnetic beads sample. The analysis detected a signal for nitrogen (N) composition, 
which was not found in the control sample. Here it is referred to the imidazolinone ring in biotin 
molecules. Although sulfur is a major element of the tetrahydrothiophene ring of the biotin, the 
EDX detector did not reveal a significant atomic percentage of it, since the instrumentation setup 
did not have a high sensitivity for sulfur element detection. 
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2.5.4 B4F Quantitative Assay 
The degree of biotinylation on the surface of the magnetic beads was determined using the 
B4F assay. This assay used the biotin-containing fluorescein molecule, B4F, to monitor the biotin 
ligand exchange in the binding sites of streptavidin by tracking the decrease in the initial 
fluorescence signal upon adding streptavidin, and the increase in the fluorescence signal upon 
Element Weight % Atomic % 
C K 13.96 26.58 
N K -0.48 -0.78 




S -0.32 -0.23 
Fe 2.46 1.01 
Totals 100.00  
Element Weight% Atomic% 
C K 19.23 33.60 
N K 1.62 2.43 
O K 12.29 16.12 
Si K 61.29 45.79 
S K -0.12 -0.08 
Fe K 5.68 2.13 
Totals 100.00  
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adding a different biotin analogue that will displace B4F from the streptavidin, releasing them in 
solution.  
The results of the assay showed a significant biotin labelling on the beads (Figure 2.13). 
The concentration of B4F in sample (3) deduced from the B4F amount in sample (2) yielded a 
concentration of 350.63 nM of B4F that was displaced by the biotins on the beads, which 
corresponds to the total quantity of biotins found on the surface of the magnetic beads (Figure 
2.13). Multiplying this value by the dilution factor (800/2.13), a biotin concentration of 131.7 µM 
was attained in the original magnetic beads sample. The original sample of the magnetic beads 
contains 150 µM COOH surface carboxyl groups that could be biotinylated. Achieving biotin 
concentration of 131.7 µM on the beads surface, yields 87.8% surface labelling. The experiment 
was duplicated, sample (4), and 131.4 µM (87.6 %) yield was attained with 0.24% error.  
 
Figure 2.13. B4F assay analysis bar chart indicating the successful displacement of B4F 



















(2) SA 100 nM +
B4F 400 nM
(3) SA 100 + B4F
















2.5.5 Ferritin-avidin Network 
Section 2.4.6 presented the experimental setup employed to investigate the protein network 
formation. The capsule protein that was used as a building block for the network is the horse spleen 
ferritin, which is an excellent choice due to possessing an iron core that makes the network feasible 
to be visualized under the scanning electron microscope without sample staining treatment, as the 
core exhibits a bright spherical entity. Biotinylated ferritin was prepared using the biotin-PEG24-
TFP reagent to label the ferritin surface with biotins that bind non-covalently to biotin-binding 
sites on avidin. To visualize the dimensions of the network, the Figure 2.14 illustrates a two-
dimensional bond of two ferritins mediated by avidin. The assembly is facilitated by biotins 
attached to two opposite sides of the avidin molecule. A fully extended form of this linkage in the 
network will have a total of 49 nm distance (Figure2.14) between each two ferritin capsules within 
the biomaterial. Since the PEG spacers used are flexible in aqueous solutions, the reported length 
could be less.  
 
Figure 2.14. Chemical assembly of biotin-PEG24-ferritin capsules through an avidin mediator 




The discussed protein scaffolds could be engineered with multiple levels of structural 
porosity. As elaborated earlier, the ferritin protein was targeted with variable biotin-PEGn linkers 
such as; PEG24, PEG2K, PEG5K, and others. When completely extended in solution, these 
molecular attachments that contain terminal biotins have a length of 9 nm, 18.5 nm, and 46.6 nm, 
respectively (Figure 2.15). Figure 2.15 is an illustration of a saturated avidin protein establishing 
a tetravalent attachment with four ferritin capsules cross-linked with PEG spacers of variable nano-
dimensions.  
 
Figure 2.15. Four biotinylated ferritin capsules with different PEG linker lengths are attached with 
an avidin through the biotin-binding sites. The figure utilized the structures of avidin (PDB: 
1AVD), horse spleen ferritin (PDB: 5ERK) and the chemical structure of the various PEG linkers. 
 
As Table 1 indicates, three different biotin-binding proteins; avidin, streptavidin, and 
neutravidin were utilized as mediators to form protein networks following the same procedure. All 
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experiments used a stoichiometric ratio of 1:18, Biotinylated ferritin:biotin-binding protein. Figure 
2.16A-D, presents a comparison between networks that were made using the three biotin-binding 
proteins. Vial A presents the control experiment. The control is a mixture of unbiotinylated ferritin 
and avidin. The figure shows a soluble mixture of both proteins. Vial B contains a complex of 
biotinylated ferritin with avidin that resulted in the development of aggregates of amorphous 
material which is believed to be an indication of the network components assembly due to the 
avidin-biotin complexation. This result is consistent with what has been found by other 
researchers, that avidin forms visible aggregates with biomolecules that have multiple 
biotinylations (Heitzmann & Richards, 1974). A further study has shown the formation of extended 
complexes using biotinylated protein and avidin, which subsequently created large visible 
aggregates (Garanger et al., 2009). Therefore, it was concluded that the previously obtained 
research is in line with our findings. 
To expand on the protein scaffold assembly, the same experiment was carried out using 
the biotin-binding protein, streptavidin (Figure 2.16C). Interestingly, the protein network shows a 
soluble complex (Vial C). The mixture was monitored over the next 7 days to detect possible 
aggregation development; however, no visible change was noticed. Further exploration of the 
network self-assembly involved the addition of the neutravidin protein with biotinylated ferritin, 
which resulted in a soluble material, Figure 2.16D. Vial D shows no amorphous material. The 
observations in Vial C and D indicated that both neutravidin and streptavidin, do not form insoluble 
networks.  
In contrary to our results, the streptavidin protein has demonstrated the formation of 
aggregates in many studies, by which controllably aggregated materials were observed by using 
the streptavidin-biotin interaction as well (Aslan et al., 2004). Moreover, another study reported 
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that a mixture of biotinylated ferritin and streptavidin incubated for 10-15 minutes results in the 
formation of observable yellow aggregates (Li et al., 1999).  
 
Figure 2.16. Protein networks. A) Control: unbiotinylated ferritin with avidin. B) Biotinylated 
ferritin with avidin. C) Biotinylated ferritin with streptavidin D) Biotinylated ferritin with 
neutravidin. 
 
It was hypothesized that electrostatic interactions could play a role in the network assembly 
and aggregate appearance. This assumption was raised based on the isoelectric point (pI) values 
of the mediator proteins; avidin (pI = 10.5), streptavidin (pI = 5.0), neutravidin (pI = 6.3), in 
addition to the ferritin (pI = 5.0-6.0). For example, there might be an electrostatic attraction 
between modified ferritin and avidin, and repulsion among ferritin and streptavidin/neutravidin. 
The explanation of why the biotinylated ferritin would show electrostatic attraction with avidin 
(Vial B) while the unbiotinylated ferritin would not (Vial A), could be referred to the degree of 
biotinylation on the protein surface. The biotinylated ferritin utilized here was modified with biotin 
reagent at several lysine residues, which would result in less positive charge density on the surface. 
Perhaps electrostatic attraction between the modified ferritin displaying biotins and the avidin 
enhances the complexation phenomenon.  
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Further experimentation was carried out to learn more concerning the fabricated avidin-
based networks. The network with avidin was constructed in a solution of 0.3 M and 1 M NaCl. 
The electrolyte concentration in the reaction mixture could reduce the protein surface charge 
contribution to the electrostatic interaction. Figure 2.17A & B show the network prepared in a 0.3 
M and 1 M salt solution respectively. It was noticed that the presence of salt has a slight 
contribution to the solubility of the network with ionic concentration, however, clear populations 
of tiny aggregates were still observed (indicated with an arrow).  
The ease of reversibility of formation of the network assembly upon adding free D-biotin 
molecules (244.3 g/mol) was investigated. It was hypothesized that if the network was not 
extremely tight and compact, the addition of free biotin might be able to exchange out the biotin-
containing cross-linkers and dissolution of the solid complexes might result. The result of this 
experiment is shown in Figure 2.17C. The addition of 4-fold of D-biotin relative to avidin molar 
quantity has resulted in a more soluble network within 30 minutes, in comparison to the network 
in Figure 2.16A, which shows that the biotin-avidin complex of the protein network may have 




Figure 2.17. Ferritin-Avidin networks. A) A network assembled in 0.3 M NaCl. B) A network 
assembled in 1 M NaCl. C) A pre-assembled network with free D-biotin molecules added in a 4:1, 
biotin:avidin ratio. 
Additional experiments are to be carried out in order to further draw a full view of the 
ferritin-avidin protein networks. A proposed experiment would include the network formation 
using a biotin-free TFP-ester cross-linking reagent (mPEG24-TFP ester) and the reaction of this 
modified ferritin with avidin.  
In addition to observing the material in solution, a solid form was visualized as well. The 
biotinylated ferritin, produced by reaction with the biotin-PEG12-TFP reagent, was added directly 
(10 mg/ml) to avidin (50 mg/ml) on a glass slide and allowed to dry at room temperature. The 
formation of a thin film of solid amorphous biomaterial was noticed (Figure 2.18B). Figure 2.18A 
shows a control of the same ratios of unbiotinylated ferritin and avidin. This mixture had dissolved 
readily upon adding water to it, whereas the second mixture shown in Figure 2.18B, did not readily 




Figure 2.18. A) Control of unbiotinylated ferritin and avidin on a glass slide. B) A thin film of a 
solid amorphous material made of biotinylated ferritin and avidin. 
 
2.5.6 SEM Characterization  
The protein networks made of biotinylated ferritin (biotin-PEG24-TFP), and avidin proteins 
were visualized using SEM microscopy. The image depicted in Figure 2.19A was set to a 
resolution of 20 nm. It is clearly possible to observe white dots that correspond to the ferritin iron 
core of the protein network. Additionally, the EDX technique was used in conjugation with SEM 
to report the chemical elemental composition of the sample being characterized (Figure 2.19B). 
The EDX analysis reveals the identity of the bright dots to be iron, as the Fe signal was detected 
(Figure 2.19B). Distance analysis was done to measure the average distances between ferritin 
molecules using the “Fiji – ImageJ” software (Schindelin et al., 2012). The average distance 
between the particles was found to be approximately 18 nm in length. This length suggests that 
the PEG spacers between ferritin molecules are not fully extended to the maximum length of 45 
nm. Another explanation would involve the imaging dimensions of the SEM. SEM shows a two-
dimensional image, and as the material being characterized has three dimensions, any two 




dimensional structure. This results in a measurement that is not specifically reflective of the 
distance between two ferritin capsules. 
 
Figure 2.19. A) SEM image of biotinylated ferritin (PEG24-TFP)-avidin material B) EDX 






2.5.7 The Effect of Enzyme-bound Ferritin-avidin Network on PET Degradation 
An enzymatic-bound ferritin-avidin scaffold was prepared and washed as described in 
Section 2.5.10. The use of BSA was required in the washing step in order to exclude the protein-
protein non-specific van der Waals interactions that emerge upon mixing the biotinylated HiC 
enzyme with the ferritin-avidin scaffold. To explore the non-specific interactions, the Schrodinger 
software was employed to map the hydrophobic patches on the surface of HiC cutinase (PDB: 
4OYY) and avidin (PDB: 1AVD), both illustrated in Figure 2.20. Significant regions of 
hydrophobic residues on the HiC enzyme surface appear in green in Figure 2.20A, which are 
believed to contribute to the surface adsorption to the avidin in the scaffold, which also contains 
some hydrophobic surface residues (Figure 2.20B). 
 
Figure 2.20. Surface mapping of the hydrophobic patches responsible for non-specific 
interactions between: A) HiC enzyme (PDB: 4OYY) and B) avidin protein (PDB: 1AVD). 
Hydrophobic regions are shown in green. Images were generated using Schrödinger software. 
(Schrödinger Release 2020-2: BioLuminate, Schrödinger, LLC, New York, NY, 2020). 
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Excluding non-specific interactions helped in keeping only the enzymes that were affixed 
to the material through the biotin-avidin interaction. The presence of BSA and Tween 20 detergent 
in the solution helped in improving the dispersity and in reducing the non-specific interactions 
between proteins. Moreover, the HiC enzyme molecules were also found to adhere to surfaces 
such as tubes or pipette tips, as was previously determined by Jameson Pfeffer (Pfeffer, 2019). 
Therefore, the washing step was also used to avoid the participation of free enzyme molecules 
during the enzymatic activity assay that were initially bound to the tube and not to the protein 
scaffold. 
In the control experiment with no enzymatic scaffold, the results obtained from scanning 
electron microscopy experiments from PET plastic incubation with free HiC enzyme solution at 
55 °C and room temperature are shown in Figures 2.21 and 2.22, respectively. The micrographs 
in Figure 2.21B & D show the PET section with severe digestion as a result of 19 days incubation 
with the HiC enzyme at 55 °C. While Figure 2.22B & D show no evidence of enzymatic damage 
when incubated with HiC solution for the same duration at room temperature. These results were 




Figure 2.21. A, C) SEM micrographs of PET plastic exposed to 200 mM sodium phosphate 
buffer at pH 7.0. at 55 °C for 19 days. B, D) SEM micrographs of PET plastic exposed to 20 







Figure 2.22. A, C) SEM micrographs of PET plastic exposed to 200 mM sodium phosphate 
buffer at pH 7.0. at room temperature for 19 days. B, D) SEM micrographs of PET plastic 
exposed to 20 mg/ml HiC enzyme solution. Images A/B and C/D were taken with 1500 x and 






The effect of the fabricated enzyme scaffold on digesting PET plastic was also examined 
by monitoring the surface morphology of PET. The PET segments were incubated with the 
enzyme-bound scaffold at room temperature for 15 days. The subsequent PET surface damage as 
a result of HiC digestion of PET polymers was visualized using SEM to monitor the evidence of 
PET surface damage as a result of digesting PET polymers, caused by the esterase activity of the 
enzymatic scaffold during incubation. First, control samples were prepared for comparison. 
The next figure presents a set of control images on untreated PET with 1500x and 20,000x 
magnification.  Figure 2.23A & C shows a sample of dry PET with no enzyme exposure, and 
Figure 2.23B & D is for a sample was exposed to 200 mM sodium phosphate buffer, pH 7.0 buffer 




Figure 2.23. SEM images of PET samples incubated at room temperature for 15 days. A, C) 
Image of untreated dry PET section taken with 1500 x and 20,000 x magnification. B, D) 
Untreated PET section exposed to 200 mM sodium phosphate buffer, pH 7.0 with 1500 x and 






Next, the enzymatic scaffold exposure effect was tested on the PET sections. Figure 2.24 
displays the hydrolysis effects of exposure to an enzyme-bound scaffold over 15 days of room 
temperature incubation. The images obtained exhibit obvious instances of damage to the studied 
sample of PET plastic. More notably, is the observation of an apparent hole in the PET section 
caused by the HiC scaffold. The micrographs in Figure 2.24 A, C & E correspond to one spot on 
the PET section and present subsequent magnification. These images were generated by a 
secondary electron (SE) detector. While the micrographs in Figure 2.24 B, D & F that correspond 
to a second spot in the same PET sample, were generated by a backscattering (BS) electron 
detector. BS detector can be more useful in providing more topographic information by the 
maximized contrast, which is clearly noticed in the micrograph, since it relies on the elastic 




Figure 2.24. SEM images of PET after digestion by the enzyme-bound scaffold over the duration 
of 15 days at room temperature. The micrographs were taken with 1500 x, 20,000 x, and 118,146 
x magnification. Images A, C, and E were taken using an SE detector, and images B, D, and F 
were taken using a BE detector. 
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The scanning electron microscopy imaging of PET plastic incubated with the enzymatic-
scaffold was consistent with degradation similar to that observed by the enzyme alone. However, 
the enzymatic scaffold was more successful than the soluble free enzyme in causing PET 
degradation at room temperature, while the soluble enzyme required elevated temperature to 
exhibit a damaging effect.  
2.5.8 Photolytic Behavior of PC biotin-PEG3-NHS Carbonate Ester Containing Protein 
Network 
In this part of the project, we explored the use of a photo-responsive PEG spacer in the 
design of the ferritin-avidin network. HSF was modified using the PC biotin-PEG3-NHS carbonate 
ester, a known labile photocleavable cross-linker. The ferritin-avidin network containing ferritins 
modified with the photocleavable linker was then exposed to UV light at 365 nm for 0, 30, and 45 
min (Levalley et al., 2020). Initial attempts were performed by pipetting the sample in a closed 
plastic centrifuge tube; however, this way did not result in chemical bond photolysis due to the 
presence of a physical barrier, the plastic tube. Therefore, a polystyrene microplate was used, 
which substantially improved the PEG reagent photolysis process.  
The results of the MALDI-TOF analysis for the ferritin-avidin photocleavable protein 
network after undergoing UV radiation exposure at 365 nm for 0, 30, and 45 minutes are shown 
in Figure 2.25. Spectrum A is the mass peak of the unexposed network control corresponding to a 
peak at 15981 m/z, which is the avidin monomeric mass, and a second peak at 20066 m/z. This 
peak exhibits a significant widened peak base creating a shoulder at a mass corresponding to the 
PC biotin cross-linker, evidence that this mass peak was comprised of two components, that 
concludes a successful conjugation. Both spectra B, and C, which belong to samples with 30 and 
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45 min UV light exposure, respectively, show that the shoulder peak has completely disappeared.
 
Figure 2.25. Results of MALDI-TOF for the photolytic protein network. A) Protein network with 




Control – No UV exposure 
30 min UV exposure 
45 min UV exposure 
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The absence of the shoulder increment in the biotinylated ferritin mass peak is an 
implication of the full photolysis of the ferritin-avidin network. The photolysis of the network is 
expected to follow the Norrish type II photocleavage mechanism (Figure 2.26), where the cleavage 
occurs at the carbamate moiety of the reagent (Dalal et al., 2018).  
 
Figure 2.26. The mechanism of Norrish type II photocleavage at the carbamate moiety. 
 
As the PC biotin reagent attachment is released from ferritin, the ferritin-avidin bond 
through the biotin linker will be freely liberated in the solution causing the subsequent degradation 
of the protein network. The mass spectrometry results in Figure 2.25 confirm that the network was 
successfully photocleaved within 30 minutes of UV light exposure. An image of this photolyzed 
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network is presented in Figure 2.27, which shows a dissolved material as a result of the UV light 
exposure that triggered the carbamate moiety cleavage.  
 
Figure 2.27. Ferritin-avidin network exposed to UV light at 365 nm for 30 minutes. 
 
Based on these findings, the strategy of exploiting a controlled labile drug compound in 
the ferritin-avidin network seems to be a promising approach that can be pursued to for medical 
applications to fabricate a self-healing protein nanomaterial bandage. Figure 2.28 is a scheme for 
the design of a protein-based smart bandage that releases the drug Besifloxacin.   
 
Figure 2.28. The design of functionalized protein networks with photocleavable drug molecules 
for medical applications (e.g. Smart bandages). 
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3 Chapter 3: Development of a New Bioconjugation Strategy 
3.1 Introduction  
Tris-2-carboxyethyl phosphine (TCEP) (Figure 3.1A) is a water-soluble reducing agent used 
in protein modification and organic synthesis preparatory steps to reduce even the most stable 
disulfide bridges between cysteine residues and sulfhydryl alkyl molecules (Liu et al., 2010). This 
reducing agent is a mandatory step prior to protein bioconjugation reactions to produce free-thiol 
nucleophilic cysteines, making them ready for alkylation via a cross-linking compound, typically 
with a maleimide-containing molecule in a bioconjugation reagent. The double bond of the 
maleimide ring (Figure 3.1B) undergoes alkylation by sulfhydryl residues to form a stable 
thioether bond, occurring through a typical Michael addition reaction.  
 
Figure 3.1. Chemical structure of A) Tris-2-carboxyethyl phosphine (TCEP) reducing agent, and 
B) N-Ethylmaleimide. 
 
TCEP is odorless, and it is more stable as a reducing agent than dithiothreitol (DTT) or β-
mercaptoethanol (BME), in addition to being more effective over a wider pH range (Liu et al., 
2010). Using phosphine-based reducing agents as a replacement to the thiol-based agents is more 
favorable as they are interact more rapidly, have a physiological pKa (i.e. 7.4) suitable for a wide 
range of bioconjugation reactions, in addition to their reaction being irreversible when reducing 
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the disulfides, unlike thiol-based reducing agents that can oxidize the sulfhydryl groups back to 
disulfide bridges in a reaction mixture (Kantner et al., 2017). 
A different aspect of TCEP functionality is considered in this chapter. The common 
protocols for disulfide reduction suggest that there is no need to remove TCEP from the reaction 
mixture before introducing the maleimide-based conjugation reagent (Kantner & Watts, 2016). 
Contrary to this, some articles in the literature have demonstrated that the nucleophilic 
phosphorous atom of TCEP is reactive towards the Michael acceptor, maleimide, producing a 
stable TCEP-MAL ylene incapable of interacting with the cysteinyl thiols (Mthembu et al., 2020). 
A model interaction of N-ethylmaleimide (NEM) and TCEP is shown in (Scheme 3.1). 
 
Scheme 3.1. Reaction of N-ethylmaleimide and TCEP agent to form a stable ylene adduct. 
 
This hypothesis was evidenced by the decrease of maleimide-conjugation yields in addition 
to the formation of an unreactive side product resulting from the reaction between both 
compounds, suggesting that the maleimide reagent is being neutralized in the presence of the 
reducing reagent, TCEP (Kantner & Watts, 2016). Several techniques were utilized to support 
these observations. Moreover, the Honek group has encountered similar findings. A former 
student, Dr. Hawa Gyamfi, noticed that upon using TCEP reagent to reduce the disulfide bonds in 
Archaeoglobus fulgidus ferritin (AfFtn) protein, that TCEP inhibits the reaction between protein 
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cysteine residues and maleimido-C3-NTA, where the cysteines remained unmodified after 
incubation at different time points (Gyamfi, 2019). The mass spectrometry chromatograms of the 
AfFtn incubated with the N-substituted maleimide reagent exhibited an unmodified protein signal, 
in the presence of TCEP. Whereas, upon removing the TCEP from the reaction, all the cysteine 
residues were 100% modified with the maleimide reagent on all the subunits of the protein, 
showing that indeed there is a competitive reaction between both species. 
Another study by Kantner and his group suggested developing a method to compromise 
the reactivity of TCEP towards maleimide without having to remove the TCEP from the reaction. 
This strategy employed the PEG-azide reagents to quench the TCEP activity towards maleimide, 
which helped in retaining the protein conjugation efficiency of the cysteine-maleimide reactions 
as shown in Figure 3.2. PEG-azides were shown to be capable of oxidizing the trialkylphosphine 
molecules to constrain the phosphorous nucleophilic attack. Figure 3.2. shows an SDS gel with 
and without PEG-azide quenching of TCEP (Kantner et al., 2017). 
 
Figure 3.2. Reaction of maleimide and TCEP in the presence of PEG-azides that resulted in 
retaining the protein conjugation. Reproduced with permission under CC license from (Kantner 
et al., 2017). 
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Wittig olefination is an important organic reaction which allows for the production of an 
alkene by the reaction of a carbonyl moiety of a ketone or an aldehyde with a phosphonium salt, 
namely an ylide, which is a zwitterion compound that produces phosphine oxide as a byproduct 
(Scheme 3.2). The Wittig reaction has been extensively used in the pharmaceutical area. A 
common use is the synthesis of tetraterpenoid compounds, e.g. carotenoids, via the carbonyl 
olefination of a symmetrical or asymmetrical Cx-dialdehyde with two equivalences of an 
appropriate Cx-phosphonium salt (Bogacz-Radomska et al., 2020). The generalized N-substituted 
maleimide-alkyl phosphorous adducts were demonstrated to undergo Wittig reaction with 
aldehyde derivatives under certain conditions (Bogacz-Radomska et al., 2020). Literature reviews 
have reported a diverse range of organic synthesis conditions that require a heating step at a 
temperature in the range 50-100 °C, over a 1-12 hour period, and the required use of different 
concentrations of base catalysts, while other articles reported no use of a base catalyst (Kim et al., 
2017) (Bayat et al., 2017) (Brackman et al., 2013). This reaction with an aldehyde produces a 
mixture of E- and Z-olefins (Thiemann, 2007) (Scheme 3.2), with the E configuration to be more 
dominant (Bayat et al., 2017) and thermodynamically more favorable isomer. 
 
Scheme 3.2. Wittig reaction mechanism of an N-Ethyl maleimide-TCEP adduct with an aldehyde 
that produces E- and Z- alkenes, with the E-isomer being more thermodynamically favorable, 
and phosphine-oxide as a byproduct. 
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With respect to protein modification reactions, a wide array of functional groups can be 
covalently and irreversibly introduced site-specifically to a protein of interest via a Wittig reaction. 
The traditional method is the olefination of an existing aldehyde group on a protein. Aldehydes 
are not naturally available within proteinogenic amino acids, however, incorporating an aldehyde 
handle within the amino acid sequence of a protein can be achieved through different strategies, 
such as the chemical installation of tags, the enzymatic incorporation of probes, or the site-specific 
incorporation for non-native carbonyl-containing amino acids (Agten et al., 2016). Nevertheless, 
the carbonyl’s electronic properties will differ according to the employed strategy (Spears & 
Fascione, 2016). Recent bioconjugation studies on enabling the Wittig olefination reaction on 
aldehyde-tagged proteins reported a 65% yield determined by ESI- and MALDI-MS (Han et al., 
2012). This approach has shown promising applications, by which studies have demonstrated 
tangible potential for protein tracking in live cells via Wittig enhanced fluorescence tagging 
(Spicer & Davis, 2014). Other applications were described by the successful streptavidin-mediated 
affinity isolation of proteins, through the Wittig conjugation of a biotin-phosphonium salt on an 
aldehyde-functionalized FKBP12 protein (Lum et al., 2013).  
Wittig reactions are commonly performed and work well with solvated adducts in an 
organic-aqueous environment. On the other hand, performing Wittig reactions employing polymer 
supported resins containing trialkylphosphines instead of the free phosphines can result in a more 
efficient strategy as it can be considered more environmentally and economically friendly. 
Moreover, a resin-based approach has been reported to afford purer olefin products and eliminates 
the sometimes-difficult removal of the phosphine oxide byproduct by having it remain attached to 
a polymer, which is easily separated from the desired product (Moussa et al., 2019). More 
advantages offered by the utility of solid supported resins might also be realized if they were 
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employed in strategies to immobilize target enzymes onto these resins, providing enzyme-attached 
resins capable of possibly increased stability and ease of recycling from a reaction mixture 
(Mohamad et al., 2015).  
3.2 Objectives  
This chapter outlines the detailed methodology that was followed to investigate the 
viability of a multi-step strategy to achieve a new approach to protein bioconjugation. The 
approach will be to attach a maleimide-based functionality to the surface of a protein, reacting this 
maleimide with TCEP to form a reactive ylide, and then to attempt to utilize this functionality to 
perform a Wittig reaction with an aldehyde to finally produce a modified protein. We decided to 
exploit former research findings in this area, supported by our group’s observations, in order to 
generate a strategic approach to indirectly bioconjugate PEG-aldehyde-containing molecules to a 
ferritin surface, further allowing to incorporate a select aromatic aldehyde to protein networks. The 
protein used in this project, ferritin, is not rich with cysteine amino acids and contains only one 
unexposed residue. Our previous trials in modifying this cysteine were not fruitful, therefore we 
decided to employ a heterobifunctional cross-linking reagent, NHS-PEG4-maleimide, that might 
be expected to be bioconjugated to lysine residues -which are abundant on the surface of ferritin- 
at one end and will expose a solvent-accessible maleimide group on the protein surface at the other 
end. To the best of our knowledge, no studies have been undertaken that employ this strategy. If 
successful, the approach would allow a protein to be modified with a maleimide functional group 
and allow for a wide array of aldehydes to be attached to the protein for applications in biophysics, 




Scheme 3.3. A novel bioconjugation strategy on ferritin proteins aims to attach a wide array of 
aldehyde molecules via Wittig olefination. 
 
 
3.3 Materials  
The following compounds were obtained from the noted commercial resources: Tris(2-
carboxyethyl)phosphine hydrochloride, (TCEP.HCl; <= 100%; Sigma-Aldrich, Canada). N-
Ethylmaleimide (NEM) (J. T. Baker Chemical Co. NJ, US). p-Anisaldehyde (98%; Sigma-Aldrich, 
Canada). MAL-dPEG®4-NHS ester (90%; Quanta BioDesign, Ltd, USA), mPEG4-benzaldehyde 
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(98%; BroadPharm, San Diego, CA, USA), Sephadex G-25 resins.  Nickel His-TrapTM HP column 
(GE Healthcare, Chicago, USA). 
3.4 Methodology   
3.4.1 Reaction of N-ethylmaleimide with Tris-2-carboxyethylphosphene 
Initial investigations were performed under mild conditions similar to protein conjugation 
reaction conditions. NEM (8.0 mg, 0.064 mmol) and TCEP (1 equiv., 18.3 mg, 0.064 mmol) were 
dissolved in 1 mL of doubly distilled water purged with argon gas for 10 min, then incubated while 
stirred for 1 hour at room temperature. The reaction mechanism is described in Scheme 3.4. The 
mixture was completely dissolved showing a clear solution with a concentration of 66 mM. After 
incubation, the adduct was analyzed and detected on ESI-MS instrumentation. 
 
Scheme 3.4. Reaction mechanism of N-ethylmaleimide with tris-2-carboxyethylphosphine 
incubated for 1 hour at room temperature. 
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3.4.2 31P NMR 
Phosphorous Nuclear Magnetic Resonance (31P NMR) spectroscopy was employed to 
verify the formation of the synthesized adduct. A sample of the NEM-TCEP adduct (7.2 mg, 300 
µL) described above, was diluted with deuterium oxide, D2O, and transferred to a new 7” NMR 
tube (NE-HL5-7”). The sample was analyzed using a 500 MHz high resolution UltraShieldTM 
Bruker spectrometer for 2-4 hours. The pulse program used was zgpg30 with pulse delay of 3 
seconds.  
3.4.3 Optimization of Wittig Olefination Reaction Conditions   
 Various attempts were pursued to react an aldehyde moiety to the TCEP-NEM adduct 
(Scheme 3.5). The p-anisaldehyde was chosen as simple aromatic model to achieve the Wittig 
product, before conducting this reaction on a protein. All of the preliminary conducted experiments 
were unfruitful, until we eventually could optimize a successful procedure that yielded the desired 
product.   
 
Scheme 3.5. Reaction scheme of NEM-TCEP adduct with p-anisaldehyde results in the alkene 





p-Anisaldehyde (136 g/mol) was chosen and first attempted as a model aldehyde to test the 
viability of an NEM-TCEP Wittig olefination with a simple aldehyde. p-Anisaldehyde (1.123 
g/mL, 0.033 mmol, 4 µL, 5 equiv.) was added to the previously prepared and verified TCEP-NEM 
adduct (6.6×10-3 mmol, 100 µL) in 20% HPLC grade ethanol solution (400 µL) as the organic 
solvent. A strong base, sodium hydroxide; NaOH (2 M, 6.6×10-3 mmol, 3.3 µL) was added to the 
reaction mixture with an adduct:base molar ratio of 1:1. The organic reaction was refluxed for 4 
hours at a temperature between 50-60 °C. The reaction was then permitted to cool to room 
temperature, followed by solvent evaporation to remove ethanol under reduced pressure using 
rotary evaporator (Rotovap) prior to analysis.  
 Moving forward through the aldehyde conjugation plan, the reagent m-PEG4-
benzaldehyde, 268.3 g/mol, which is the aldehyde of interest, was purchased from BroadPharm® 
(95% purity; BroadPharm, San Diego, USA).  To test the validity of the purchased aldehyde 
derivative in undergoing a Wittig olefination, a reference standard compound of NEM-mPEG4-
benzaldehyde was prepared and analyzed by following the previously optimized procedure, the 
same that utilized the p-anisaldehyde.  
3.4.4 HSF Protein Surface Modification  
3.4.4.1 Conjugation of Maleimide Linkers to the HSF Surface 
Horse spleen ferritin (10 mg/mL) was incubated with an approximately 200-fold molar 
excess of NHS-PEG4-MAL reagent (Figure 3.3) to the capsule protein in 150 mM potassium 
phosphate buffer at pH 7.4 for 1 hour at room temperature. After incubation, the sample 




Figure 3.3. The chemical structure of the bioconjugation reagent MAL-dPEG®4-NHS ester 
 
3.4.4.2 MAL-TCEP Adduct Formation on HSF surface  
TCEP (3.6 µg, 1.248×10-5 mmol, 40 µL, 1 equiv.) was added to the HSF protein sample 
(0.5 mg, 1.248×10-5 mmol, 10 µL). This protein sample contained 1.248×10-5 mmol of conjugated 
PEG4-maleimide linker. A stock solution of TCEP (1.26 mg, 14 mL) was first prepared in DDH2O 
for serial dilutions. The TCEP stock was degassed by argon purging for 10 minutes prior to adding 
to the reaction vial to lower the chance of TCEP oxidation with air molecules in water, since the 
product of oxidation, TCEP-oxide has the potential to decrease the yield of TCEP-MAL adduct 
formation. The reaction vial was kept at room temperature, 25 °C, for 1 hour before MS analysis. 
3.4.5 Modified-HSF Sample Preparation for MS Analysis  
3.4.5.1 C18 ZipTips: Reverse Phase Chromatography 
Labelled PEG4-MAL-TCEP protein samples were prepared prior to the ESI-MS run by 
using reverse phase chromatography, C18 ZipTips (Millipore Sigma, Oakville, Canada). The 
starting concentration of the modified protein sample was 50 μM. With a micropipette set to 10 
μL, the ZipTip was installed and wetted by aspirating for 7 times using a solution of 100% 
acetonitrile and 7 more times using 0.1% (v/v) formic acid. The pipetted solution was discarded 
each time. Then the protein sample was slowly loaded onto the ZipTip by aspirating for 15 times 
and expelling the sample back into the tube each time. Afterwards, a sample washing step was 
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employed. This was performed by aspirating in 0.1% formic acid for 7 times and discarding the 
liquid into waste each time. Finally, to elute the purified protein, it was aspirated into a 50 μL 
solution of 1:1 MeOH:H2O containing 0.1 % formic acid (FA) and expelled in the tube. The 
desalted sample was injected into the ESI-MS instrument in a positive mode setting.  
3.4.5.2 Centrifugal Spin Filtration   
A second sample preparation protocol was optimized using spin filters (Amicon® Ultra-
0.5; 10 kDa MWCO) to assist in gaining a sufficiently pure and concentrated sample prior to mass 
spectrometric analysis. To first verify the validity of this method and to avoid loss of the modified 
HSF protein sample, a native unmodified HSF was tested first. Horse spleen ferritin (55 mg/mL) 
was incubated in a 5% formic acid solution with a volume ratio of 1:10, acid:protein, in a total 
volume of 10 µL. This concentration of formic acid is needed to dissociate the protein capsule and 
to protonate the subunits. The washing step started with pipetting the 10 µL sample in an Amicon® 
filter with 400 µL of 0.1% formic acid which was then spun in the centrifuge for 10 min at 8960 
x g. This step was repeated twice. Two more spins were done using a solution of 1:1 
MeOH/H2O:0.1% formic acid. After the last round, the filtrate was collected and diluted to the 
desired concentration with a solution of 1:1 MeOH/H2O:0.1% formic acid, then injected into the 
electrospray mass spectrometer with a voltage setting of 4.6 kV, temperature of 300 °C, and a 
resolution of 17,500.  
3.4.5.3 Gel Filtration Purification of Ferritin-MAL-TCEP Conjugate 
 The column was equilibrated with filtered and degassed fresh 0.1% formic acid solution at 
pH 2.64. A 100 µL sample of ferritin-MAL-TCEP was diluted in 400 µL of 0.1% formic acid. The 
diluted sample was then injected onto the column, then isocratically eluted. The protein sample 
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was collected and concentrated using the SpeedVac Vacuum concentrator. The overall process of 
purification and concentration required 48 hours before injecting in ESI-MS, while the sample 
remained in 0.1% formic acid throughout the procedure.  
3.4.6 Expression and Purification of PfFtn 
 Another member of the ferritin superfamily was explored in this project, the His-tagged 
Pyrococcus furiosus ferritin, which was designed by Dr. Honek and synthesized commercially by 
Genescript Inc. The PfFtn plasmid (PfFtn-pET-22b) that encodes for the C-terminal His6-tagged 
PfFtn construct was transformed into bacterial BL21 Escherichia coli (E. coli) cells via heat shock 
(Gyamfi, 2019) 
 Luria Bertani (LB) agar plates were prepared using 2.5 g Bio-Tryptone, 1.3 g yeast extract, 
2.5 g NaCl, 3.75 g agar. The media was autoclaved for 45 minutes (25 min/25 min “dry”), liquid 
cycle. Once cooled to 50 °C, ampicillin (100 µg/mL) was added to the media. LB-broth-amp was 
poured in six petri dishes and kept at room temperature until complete solidification. A bacterial 
stab culture was made by introducing a pipette tip of BL21 E. coli cells deep into a 5 mL solution 
of LB-amp broth, then incubated overnight in a 37 °C, 220 rpm/min shaker until a cloudy broth 
was visible. The cloudy bacterial broth was streaked on the agar plates in a zig-zag fashion using 
a wire inoculating loop. The agar plates were incubated for 16 hours in a 37 °C incubator. A single 
colony from the plate was inoculated in a 100 mL LB-amp broth then incubated overnight in a 37 
°C, 220 rpm/min shaker to grow the bacterial culture. An aliquot (20-50 mL) of the overnight 
grown culture (100 mL) was inoculated in a 1 L solution of LB media (10 g Bio-Tryptone, 5.2 g 
yeast extract, 10 g NaCl) containing 100 µg/mL of ampicillin. The optical density (OD600) of the 
inoculated large media started at 0.05, and was measured using a UV-vis spectrophotometer. The 
media was re-incubated a 37 °C, 220 rpm/min shaker until 1.2 OD600, where the expression of 
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PfFtn protein was induced by adding isopropyl β-d-1-galactoside, (IPTG; 1 mM, 238.3 mg) which 
is known to bind to the lac repressor to trigger the transcription of lac operon genes to encode the 
protein of our interest. The culture was incubated again for 4 hours. The bacterial cells were 
harvested by centrifugation for 30 min using the “Beckman” JA14 rotor at 6000 x g. The harvested 
cell pellets weighed 5.15 g. The harvested cells were suspended in a 50 mL lysis buffer (150 mM 
NaCl, 50 mM MOPS, pH 7.5). Meanwhile, a protease inhibitor, 1 mM of phenylmethylsulphonyl 
fluoride (PMSF), was added in the suspension to inhibit the activity of cell proteases upon their 
release from the cells. Afterwards, the cells were physically homogenized in a manual Dounce 
glass tissue grinder while placed in an ice bucket. The suspended cells were lysed under high 
pressure to break open the cells using an Avestin Emulsiflex-C5 (Mannheim, Germany) at 17000 
psi. The lysate was heat shocked in an 80 °C water bath for 10 min to destroy all the biomolecules 
that cannot tolerate this elevated temperature. Cell debris and heat damaged, or insoluble proteins 
were pelleted down by centrifugation using Beckman JA25.5 rotor at 18,000 g for 40 min and the 
supernatant was pipetted out and filtered through a 0.45 µm nylon syringe filter prior to column 
purification.  
 Immobilized metal affinity chromatography (IMAC) purification method was chosen to 
purify the polyhistidine-tagged PfFtn via the affinity interaction of histidine to immobilized Ni2+. 
The 1 mL Nickel His-TrapTM HP column (GE Healthcare, Chicago, USA) was attached to a Bio-
Rad chromatography system (BioLogic Duo Flow instrument). The column was equilibrated with 
binding buffer (150 mM NaCl, 5 M GdnHCl, 20 mM imidazole, 50 mM MOPS, pH 7.5). The 
cleared lysate was loaded onto the IMAC column, then washed by pumping 10 column volumes 
(CV) of binding buffer to allow unbound proteins to flow through the column. The bound protein 
was eluted with 150 mM NaCl, 5 M GdnHCl, 300 mM imidazole, 50 mM MOPS, pH 7.5. The 
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purity of the eluted fractions was later tested using 15% sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE). Positive-ion mode ESI-MS was used to validate the mass of the 
PfFtn protein subunit. The expected monomeric mass of PfFtn is 21,374 Da, obtained using the 
Expasy Compute pI/Mw tool. The protein sequence is shown in Figure 3.4.  
 
Figure 3.4. The amino acid sequence of His6-PfFtn construct. 
 
3.4.7 Preparation of PfFtn-MAL Conjugate 
 Expressed and purified His6-tagged Pyrococcus furiosus ferritin (PfFtn) was utilized to 
pursue capsule protein modifications with a soluble maleimide reagent. PfFtn stock solution was 
stored in 25 mM HEPES buffer and 150 mM NaCl in a -20 °C freezer. A 3 mg/mL fresh stock 
solution of MAL-PEG4-NHS ester reagent (513.5 g/mol) was prepared and dissolved in ≥ 99.9% 
DMSO solvent. PfFtn aliquot (0.8 mg/mL or 1.5 µM, 1.48×10-7 mmol, 95 µL) was incubated with 
MAL-PEG4-NHS ester reagent (0.015 mg, 2.96×10
-5 mmol, 200 equiv., 5 µL) and kept overnight 
in a 4 °C fridge. It was vital to keep a low concentration of DMSO in the reaction mixture, as low 
as 5%, to maintain the protein’s native state and avoid unfolding. After incubation, the sample was 
desalted using Amicon® spin filters, 10 kDa MWCO, by adding 400 µL of DDH2O to the protein-
conjugate sample over 5 rounds of filtration at 6720 x g. The sample was retrieved from the filter 
membrane and diluted with DDH2O to a concentration of 0.3 µM. An aliquot of this sample was 
then diluted to 0.03 µM using an acidic solution of 1:1 MeOH/H2O:0.1% FA, as a preparatory step 
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for ESI analysis to protonate and decluster the protein sample. The sample was injected into the 
ESI instrument employing the positive-ion mode.  
3.4.8 Preparation of PfFtn-MAL-TCEP Conjugate 
 The previously prepared PfFtn-MAL sample (0.3 µM, 1.36×10-7 mmol, 440 µL) was used. 
A 1 mg/mL stock solution of TCEP was prepared in DDH2O and further diluted to 4.5×10
-4 mg/ml, 
where a sample (10 µL, 1.63×10-6 mmol) of the dilute TCEP solution was added to the PfFtn-
MAL. The molar excess of TCEP used in this reaction was quantified to be 1 equivalent to a 
protein capsule and 12 equivalents to maleimide molecules cross-linked on the capsules, since 
each capsule was modified with an estimation of 12 molecules of PEG4-MAL, according to 
MALDI-MS analysis. The reaction mixture of PfFtn-MAL-TCEP was incubated overnight at 4 °C 
and desalted the next day with DDH2O for further analysis by mass spectrometry. 
3.4.9 Reaction of mPEG-benzaldehyde with PfFtn-MAL-TCEP Conjugate 
The sample of PfFtn-MAL-TCEP conjugate that remained in DDH2O after the previous MS 
analysis (0.3 µM, 1.49×10-10 mmol, 410 µL) was mixed with the mPEG4-benzaldehyde reagent (1 
equivalent) and sodium hydroxide base (1 equivalent). This reaction mixture was pipetted in a 
round bottom flask, size 19/22, attached to a Liebig condenser over a hot water bath of 60 °C. The 
reaction was heated for four hours. Subsequently, the heated sample was cooled before employing 
the sample preparation protocols for ESI MS as previously described. Next, the sample was 





3.5 Results and Discussion 
3.5.1 Characterization of the Reaction of N-ethylmaleimide with Trialkylphosphine 
ESI MS was used in the positive ion mode. The ESI MS analysis revealed the adduct 
(375.11 g/mol) identity as one distinctive high intensity mass peak at 376.1172 m/z (Figure 3.5), 
which belongs to the [M+H]+ mass of the protonated product. This reaction is a rapid chemical 
reaction, as the spectrum shows no mass peaks of any trace starting material, NEM (MW: 125 
g/mol) nor TCEP (MW: 250 g/mol). Reference standards of these compounds, NEM and TCEP, 
were run to confirm that indeed they do appear in the mass spectrum of these compounds. 
 
Figure 3.5. The product of the TCEP and NEM reaction exhibiting a mass peak at 376.1172 m/z 
on ESI MS. 
 
3.5.2 31P NMR Evaluation 
The synthesis of the desired compound was verified using 31P NMR (500 MHz) in D2O. 
The analysis of the 31P NMR spectrum exhibited two doublet phosphorous 31P resonance signals 
(Figure 3.6), one of which is a characteristic of the ylide product of the NEM-TCEP adduct 
chemical shift at δ = 39.89-39.97 ppm. The second peak corresponds to the phosphorous resonances 
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of the TCEP-oxide compound at δ = 57.43-57.69 ppm. The signal 31P resonance of the adduct that 
was synthesized is consistent with the literature data reported previously by Kantner et al (2016). 
Similarly, the byproduct signal peak is consistent with earlier findings reported by Martindale et al 
(2016). The presence of doublet peaks suggests two forms of the desired product, which is explained 
by the incomplete deuteration of the NEM-TCEP compound in the reaction vial, where it contains 
a mixture of monodeuterated species and methine protonated species are incompletely decoupled.   
 
Figure 3.6. The 31P NMR spectrum of the NEM-TCEP product at chemical shift δ = 39.89-




3.5.3 Wittig Olefination Reaction of the TCEP-MAL Conjugate with Aldehyde Derivatives 
To optimize the Wittig olefination procedure of TCEP-MAL with aldehyde compounds, a 
simple model reaction using p-anisaldehyde was pursued to validate the reaction before moving 
forward with the aldehyde-protein conjugation, as described in Section 3.3.3. The addition of the 
base may be critical in this type of reaction since it works as a catalyst by deprotonating the 
phosphorous ylide intermediate to allow the positively-charged phosphorous ion, which is a strong 
electron withdrawing group, to stabilize the adjacent carbanion, to attack the aldehyde.  
Attention was paid to the concentration of NaOH and ethanol used in this reaction model. 
The concentration of NaOH needed for catalysis was lowered to the minimum possible quantity, 
a 1:1 molar ratio of adduct:base, because this protocol will be applied subsequently to a protein. 
The presence of an excess amount of a base has unfavorable consequences on proteins, such as 
amino acid deprotonation to form dehydroalanine residues or base-catalyzed racemization causing 
L-amino acids to partially racemize to the D enantiomer (Ebbers et al., 1997). Another point to 
keep in consideration is the concentration of ethanol as the co-solvent. Many organic-based 
procedures reported using pure anhydrous (99%) ethanol or methanol for a similar reaction (Jung 
et al., 2013) (Ha et al., 2011). Pure ethanol would denature most proteins so instead, a 20% ethanol 
solution was employed, and it was found to work as well for this simple model reaction.  
ESI MS was used to confirm the product formation. The anticipated mass spectrum that 
corresponds to the NEM-anisaldehyde product as a result of the Wittig reaction was successfully 
obtained at 246.1129 m/z (Figure 3.7). A second mass peak belonging to the starting material 




Figure 3.7. MS spectrum shows two distinct peaks of the aldehyde product at 246.11 m/z and the 
starting material at 376.11 m/z. 
 
After confirming the Wittig reaction product using p-anisaldehyde, the same procedure 
was followed moving forward through the aldehyde conjugation plan. The desired aldehyde 
reagent to be cross-linked on the target ferritin protein was to be a water-soluble aldehyde with a 
hydrophilic PEG chain. First, the reaction of the PEGylated aldehyde compound, mPEG4-
benzaldehyde, with NEM-TCEP adduct was confirmed. The detailed reaction mechanism is 




Scheme 3.6. Wittig reaction mechanism of NEM-TCEP and mPEG-benzaldehyde. 
 
As for the model experiment, ESI MS was employed for mass detection. The predicted 
mass peak for the NEM-mPEG4-benzaldehyde product as a result of the Wittig reaction was 
successfully observed at 378.19 m/z (Figure 3.8). Since the PEGylated aldehyde compound 
showed reactivity towards the ylene adduct, it was employed to further pursue selective 
conjugation on a protein surface. The mass peak intensities in Figure 3.8 exhibit a qualitative 
analysis of the analyzed products. Molecules exhibit differences in their ionization properties, 
where a low intensity mass peak in a certain spectrum is not necessarily proof of a low 






Figure 3.8. ESI spectrum shows two distinct peaks of the aldehyde product at 378.19 m/z and the 
starting material of the aldehyde reagent at 269.13 m/z. 
 
3.5.4 MALDI Analysis of MAL-TCEP Adduct Formation on the HSF Surface  
As it was confirmed that an aldehyde moiety can react with a maleimide-TCEP molecule 
and replace the trialkyl phosphonium moiety by performing a Wittig olefination reaction, the next 
step was to implement these findings on a protein. The first step was to modify the protein with a 
maleimide moiety. Herein, the maleimide groups were attached to the surface of the capsule 
protein, horse spleen ferritin (HSF), via NHS-PEG4-MAL reagent that is targeted to attack the 
surface lysine residues, forming a covalent amide bond with the lysine side chains. As mentioned, 
this approach was employed due to the lack of the accessible cysteines on the HSF surface which 
limits the ability to integrate maleimide groups to the protein surface via the sulfhydryl groups of 
the cysteines directly, which would then have employed a bis-maleimido-containing reagent. 
MALDI-TOF MS instrumentation was used to generate a protein spectrum of HSF-PEG4-MAL 
(Figure 3.9A). After confirming the successful maleimide conjugation with the HSF protein, TCEP 
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was added to the reaction mixture to form an adduct with free maleimides on the HSF surface. As 
the reaction of maleimide and TCEP is rapid and thermodynamically favorable, only one molar 
equivalence of TCEP was added to the HSF-MAL solution. The MALDI result of the HSF-MAL-
TCEP product is presented in Figure 3.9B. MALDI-TOF MS was employed to confirm the mass 
of the products, as the ESI mass spectrometry technique was not successful in detecting ferritin 
subunits as previously mentioned in an earlier chapter. As shown in Figure 3.9, spectrum A, the 
HSF-PEG4-MAL sample, displays two peaks, a ferritin subunit and a maleimide-modified ferritin 
subunit. Spectrum B of Figure 3.9 shows the peak of the HSF-MAL-TCEP product. Although 
sample B was treated with TCEP, spectrum B resembles that of spectrum A. The TCEP attachment 
to the maleimide on ferritin should result in a mass peak at approximately 20648 m/z, but instead, 
the peak is at 20470 m/z, this is a protein-PEG4-MAL peak. Therefore, either the TCEP did not 
attack the maleimide groups or the choice of MALDI-TOF mass spectrometry is not the best 
choice, since MALDI is not sensitive enough to small mass additions when the linear mode is 
used, and it provides a low resolution for these additions.  
 
Figure 3.9. MALDI-TOF mass spectra of HSF conjugation. A) Spectrum of a mass peak at 
20042 m/z, corresponding to the mass of a single native unmodified ferritin subunit with a side 
shoulder peak at 20399 m/z suggesting ferritin subunits were labelled with one PEG4-MAL 
molecule. B) A mass peak of a single unmodified subunit at 20113 m/z with a shoulder peak at 
20470 m/z that corresponds to one PEG4-MAL modification. 
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Moreover, the same reaction was replicated, since human error is always possible to take 
place. Also, following the same procedure, different reaction mixtures with different molar 
excesses were prepared to accelerate the reaction kinetics. These mixtures were analyzed on 
MALDI-TOF MS as well. The replicated experiments resulted in spectra that were similar to the 
earlier ones, which displayed non-resolved peaks of the modification. Furthermore, it was 
attempted to employ the ESI MS technique for these samples to obtain mass confirmation of the 
protein conjugate product, where ESI MS is more quantitatively accurate and able to provide a 
precise mass value for the molecule. The sample preparation of HSF-MAL-TCEP protein samples 
prior to the ESI MS run utilized the reverse phase chromatography, C18 ZipTips. Ferritin is a water-
soluble protein and the reverse phase resin is hydrophobic. However, ferritin possesses 
hydrophobic patches in its structure (Zhang & Orner, 2011), enabling us to employ this technique. 
Following the procedure described in Section 3.4.5.1, the sample preparation using C18 ZipTips 
appeared to be unsuccessful. The protein sample was bound to the tips and poorly recovered after 
several aspirations, so the sample was minimally sufficient to result in a representative MS 
spectrum. The sample was injected in the instrument, and again, no successful TCEP attachment 
was detected during the ESI analysis (spectrum not shown).  
HSF protein samples are known to be very hard to be ejected into the gas phase in an ESI 
MS run. A close look at the literature reveals a lack in utilizing the ESI MS approach to characterize 
horse spleen ferritin, for the primary reasons that ferritin is a heavily glycosylated and iron loaded 
protein causing ion-suppression, a common problem in many non-compatible ESI samples, while 
MALDI-TOF MS is recommended for glycan-containing proteins (Zaia, 2010). Only one work in 
literature was found that employs ESI MS, with a procedure that required convoluted sample 
separation and preparation (Plath et al., 2015).  
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3.5.5 Characterization of HSF Protein 
Since difficulties were experienced with MALDI-TOF MS, the choice of employing ESI 
as an alternative to MALDI-TOF was made for a precise demonstration of the protein mass and 
further efforts were made to optimize a sample preparation protocol to obtain an ESI-compatible 
clean sample (Section 3.4.5). A purified native ferritin sample, as per the procedure reported in 
Section 3.4.5.2 was collected from the Amicon spin filter and injected in ESI MS positive ion 
mode. The peak series in the total ion chromatogram (TIC) Figure 3.10A exhibits a distribution of 
multiply charged analyte ions, a definite characteristic of a well-ionized protein sample. Figure 
3.10B is the deconvoluted spectrum of an HSF subunit obtained by BioPharma Finder TM Software 
that shows a predominant peak at 20,098 Da, which is the mass of the HSF subunit. The same 
mass value was obtained previously by MALDI-TOF MS when analyzing the same sample. The 
peak at 19,117 Da is believed to be the mass of the L-chain type of subunit, based on the fact that 
ferritin has two types of chains, H (heavy) and L (light). These results provide a good fit to the 
data obtained formerly using a different MS technique. It was concluded that the centrifugal spin 
filtration technique with the use of dilute formic acid (0.1 %) as a washing solution for ferritin 
instead of DDH2O was successful to produce a detectable ferritin sample. Exposing the protein 
sample to diluted formic acid for four consecutive rounds had contributed in a relatively significant 




Figure 3.10. A) TIC spectrum of HSF showing multiply charged protein ion peaks. B) The 
deconvoluted TIC spectrum represents an accurate mass that corresponds to one unmodified HSF 
subunit. 
 
There are reasons why there is a second mass peak at 20,111 Da along with different peaks 
around 12-13 kDa in the discussed ESI spectrum, other than the actual protein subunit peaks. As 
discussed earlier in Section (1.1.2.1), HSF is a glycoprotein, which is a challenging biomolecule 
to characterize because it contains glycan microheterogeneity in its polypeptide chains. The glycan 
composition is not equally expressed among all the ferritin subunits and other subunits may not 
have carbohydrates at all, resulting in heterogenous mixtures of subunits with non-identical masses 
in the same capsule protein. In addition to microheterogeneity, the sample was not obtained from 
a recombinant source where the masses of polypeptide chains and carbohydrate composition are 
identical, instead it was obtained from a commercially available source that was extracted from 





3.5.6 Characterization of the HSF-MAL-TCEP Adduct 
The purification of the HSF-MAL-TCEP sample using the C18 ZipTips reverse phase 
chromatography was not productive in the sample recovery step from the ZipTip. Interestingly, 
the centrifugal spin filtration method was only successful in recovering samples of unmodified 
ferritin, and not the TCEP-modified samples, because it was suspected that the TCEP attachments 
on the protein aid in binding the protein to the filter membranes. Hence this strategy did not yield 
a pure sample of the ferritin modified with TCEP attachment. Since our findings support the use 
of dilute formic acid as a washing solution for ferritin instead of DDH2O, it was decided to seek a 
different purification method. The gel filtration chromatography using Sephadex G-25 resins was 
used instead. 
The Sephadex G-25 column was equilibrated and the sample isocratically eluted with a 
very low pH of 2.64 containing dilute formic acid. The isocratic elution means that the mobile 
phase composition remained constant throughout the run. The very low pH was found to be critical 
to maintain a declustered ferritin capsule into monomer subunits, which is a requirement for ESI 
analysis. This condition will trigger the release of the encapsulated elemental iron and eliminate it 
from the protein subunits.  
The ESI MS technique produced a clearly detected protein spectrum (Figure 3.11A), which 
exhibited a very well resolved set of multiply charged fragments, a perfect chromatogram in 
comparison to any previously obtained spectrum for ferritin. The deconvoluted spectrum showed 
a significant peak at 16,950 Da (Figure 3.11B), however, this is not the reported molecular weight 
for ferritin. To further investigate, the same sample was analyzed using MALDI-TOF MS. MALDI 
analysis showed two mass peaks, suggesting two species. One distinctive peak at 16,960 Da, which 
is the same species which appeared in the deconvoluted ESI spectrum (Figure 3.11C), and a second 
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low intensity peak at 20,707 Da. The ~700 Da increment to the ~20,000 Da ferritin mass, is the 




Figure 3.11. A) TIC-ESI spectrum for the HSF-MAL-TCEP sample purified by gel Sephadex G-
25. B) The deconvoluted ESI spectrum exhibiting the mass peak of the modified protein. C) 




Yet, to explore the identity of the peak at 16,960 Da, we eliminated the possibility that the 
species of 16,950 Da protein mass belongs to an unknown component existing in the commercial 
protein stock, because after the first ferritin modification with NHS-PEG4-MAL, the sample was 
washed using a spin filter of 100 kDa MWCO. A membrane with a similar cutoff is enough to 
rinse proteins of 16.9 kDa molecular weight through the filter. A more reasonable argument to 
consider is the possible effect of formic acid being the solution surrounding the ferritin throughout 
the purification and concentration procedures. We suspected that the 0.1% formic acid solution 
possesses chemical cleavage activity towards the ferritin polypeptide chains. Given that the dilute 
formic acid was at pH 2.64, ferritin is known to survive acidic conditions down to pH 3.0 and 
retain the intact capsule structure. A complete declustering of the ferritin subunits was recorded at 
pH 2.0. Dilute solutions of 2% formic acid were found to be used for chemical cleavage at aspartyl 
residues of proteins (Li et al., 2001). The mentioned information indicates that ferritin capsules in 
0.1% formic acid solution should be declustered, but with no denatured or cleaved polypeptide 
chains. However, as mentioned in the methods Section 3.4.5.3, the sample remained in the diluted 
acid for a relatively long period, in addition to being exposed to heat while in the SpeedVac 
instrument. It was suspected that the combination of both conditions, time duration and 
temperature, have contributed to the likely protein damage. To support and investigate the theory 
of formic acid cleavage effect, Expasy peptide cutter tool (Gasteiger et al., 2003) was employed 
to determine if the estimated fragmentation is consistent with our findings. The tool predicted 12 
possible cleavage sites. Fontana & Gross stated a possible polypeptide cleavage at the aspartate-
histidine at the C-terminus of proteins in dilute formic acid (Fontana & Gross, 1986). This is 




Figure 3.12. Deconvoluted ESI spectrum that exhibits a mass peak corresponding to a cleaved 
HSF fragment after an extended treatment with 0.1% FA. Beside the spectrum is the amino acid 
sequence of HSF. The black label is the sequence corresponding to the mass in the spectrum. The 
red labelled sequence indicates the cleaved fragment. 
 
 The mass of the cleaved red labelled fragment in (Figure 3.12) equals to 3208 Da, as per 
the Expasy PeptideMass tool. This mass subtracted from the native ferritin mass (~20,000 Da) 
gives that total of 16,792 Da. A value very close to that shown by the spectrum in Figure 3.11, 
being larger by approximately 160 Da. This mass is very likely to belong to different branched or 
linear N-glycan residues distributed unevenly on the capsule surface. 
3.5.7 Surface Modification of Pyrococcus furiosus Ferritin (PfFtn) 
3.5.7.1 Characterization of the PfFtn-MAL-TCEP Adduct 
 Detection of the commercial HSF protein was problematic and time consuming. Although 
numerous attempts were made to characterize HSF in mass spectrometry, however, those attempts 
were unfruitful. As a result, it was decided to pursue the project with a different ferritin capsule 
protein. The HSF protein was substituted with the thermophilic P. furiosus ferritin (PfFtn) protein. 
The PfFtn was proved to be more feasible for mass analysis and more compatible with ESI. 
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His6-tagged PfFtn was expressed and purified by other members of the Honek laboratory 
and stocks of 0.8 mg/mL of PfFtn in 25 mM HEPES, 0.1 NaCl, pH 7.4 were stored and available 
in the -80 °C fridge. A sample of the PfFtn stock solution was desalted using DDH2O using an 
Amicon® filter, 10 kDa MWCO, and analyzed by ESI MS (Figure 3.13). This protein was readily 
detected using the MS technique. Unlike HSF, no difficulties were associated with the sample 
preparation, handling, or ionization of the recombinant His-tagged PfFtn. The multiply charged 
protein ions appeared in the TIC chromatogram (Figure 3.13A) of the detected sample, which were 
deconvoluted to their masses using BioPharma FinderTM Software. Figure 3.13B reveals a mass of 
21,374 Da for the PfFtn monomer. After conjugating PfFtn with NHS-PEG4-MAL, the ESI sample 
analysis detected a high intensity mass peak at 21,772 and 22,171 Da (Figure 3.13C), a result of 
one and two subunit modifications with the maleimide linker respectively. This spectrum showed 
a sensitive and accurate detection of a double-maleimide modification peak. The next conjugation 
that was performed was with the nucleophilic phosphorous compound, TCEP, attacking the free 
maleimide rings and generating MAL-TCEP adducts on the protein. This adduct was successfully 
detected using ESI MS. A substantial mass peak at 22,021 Da is observed in Figure 3.13D, 




Figure 3.13. A) TIC-MS chromatogram of PfFtn. B) Deconvoluted ESI MS mass spectrum of 
one PfFtn subunit. C) Deconvoluted ESI MS spectrum shows two additional mass peaks 
correspond to one and two MAL modifications. D) Deconvoluted ESI MS spectrum of the PfFtn-
MAL-TCEP product.  
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3.5.7.2 Characterization of the PfFtn-MAL-aldehyde Adduct 
 The mPEG4-benzaldehyde compound was chosen as the first aldehyde to react with a 
MAL-TCEP-modified protein as this aldehyde has a hydrophilic PEG functionality, which 
increased aqueous solubility of this aldehyde over the simple aromatic aldehyde p-anisaldehyde. 
The reference standard of NEM-mPEG4-Benzaldehyde compound was first synthesized 
successfully as mentioned in Section 3.5.3 to affirm the validity of the commercial reagent to 
undergo Wittig olefination with the ylide adduct (Figure 3.8). Since the olefination reaction of the 
aldehyde moiety with the NEM-TCEP ylide was reproducible when attempting reactions with both 
p-anisaldehyde and mPEG4-benzaldehyde, therefore, we anticipated a positive result on the PfFtn. 
His-PfFtn capsule protein was adopted in this part of the project after confronting real challenges 
in acquiring representative protein spectra and mass measurements with the HSF capsule protein, 
whereas no difficulties with handling or detecting the PfFtn capsule protein were found. Another 
key reason that motivated us to alter the protein template from HSF to PfFtn is that PfFtn is a 
thermally stable protein. It is very crucial that the conjugated protein is resistant to moderately 
high temperatures, since the Wittig olefination reaction requires a refluxing environment up to 60 
°C to yield the desired product. A sample of a previously prepared PfFtn-(PEG4-MAL-TCEP)x 
was reacted with the commercially provided compound, mPEG4-benzaldehyde, according to the 
reaction conditions determined as per Section 3.4.3. Analysis of the resulting ESI mass spectrum 
revealed a successful conjugation of the aldehyde moiety on the surface of the monomeric subunit 
of PfFtn (Figure 3.14). The spectrum revealed a peak at 22,036 Da that corresponds to the identity 
of the target PfFtn-aldehyde product (Figure 3.15).  
Utilizing His-PfFtn was a felicitous choice of a compatible capsule protein, enabling a successful 




Figure 3.14. The final product the surface functionalized ferritin. An (E)-isomer of a Wittig 




Figure 3.15. Deconvoluted ESI MS spectrum exhibits mass peaks corresponding to the final 
product formation with the mPEG4-benzaldehyde attachment. 
 
3.5.8 Purification of Pyrococcus furiosus Ferritin (PfFtn) 
 The recombinant PfFtn protein was engineered to have His6-tag at the C-terminal that 
points towards the interior of the capsule protein. His-PfFtn was purified using an IMAC 
purification column that exposes immobilized divalent metal cations (Ni2+) that interacts with the 
histidine side chains of the target protein. The purification protocol of PfFtn was elaborated in the 
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methods section (Section 3.4.6). It was expected that a protein peak in the elution chromatography 
profile (Figure 3.16B), would be observed, but instead of a peak, the elution profile was observed 
as a plateau, which was fractionated into multiple tubes, an indication that the protein was not 
purified. Fractions from the flow-through and the plateau imidazole gradient were collected and 
inspected using 15% SDS-PAGE. It was expected to observe protein bands at the imidazole 
gradient at around 21 kDa, where the imidazole should bind to the column replacing the bound 
protein. However, the gel did not reveal protein bands (Figure 3.16A). The gel reveals dark bands 
around the mass of the PfFtn, which suggested that the protein was not bound to the IMAC column. 
Although the lysate was boiled for 10 min before purification but that seemed to not be sufficient 
to decluster the 24-mer capsule to expose the His-tagged subunits. Therefore, the protein was 
further boiled for 30 min and purified again with IMAC. Fractions from the second purification 
were examined with SDS-PAGE (Figure 3.16C) and it also showed no fractions of pure PfFtn. 
Previous work done by a former student (Hawa Gyamfi; PhD thesis) was reviewed for a verified 
purification procedure. She reported that to obtain a complete declustering of PfFtn capsules, a 6 
M concentration of GdnHCl is needed in the binding buffer, while our procedure used 5 M 
GdnHCl, which was found to be insufficient. A third purification round using a higher GdnHCl 




Figure 3.16. A) SDS-PAGE gel of PfFtn protein after purification with IMAC column. B) The 
elution profile for His-PfFtn purified using IMAC. C) SDS-PAGE gel of two PfFtn protein 

















 This project has explored a new methodical strategy to enable functionalized ferritin for 
protein networks. Here it has been shown, employing mass spectrometry techniques, that a 
supramolecular ferritin protein can be tagged with aldehyde-containing molecules, by employing 
the Wittig olefination reaction in the presence of the nucleophilic phosphorous adduct NEM-TCEP 
covalently cross-linked on the protein surface and site-specifically at the lysine residues. 
Implementing this organic reaction on a protein under harsh temperature conditions was 
demonstrated to be completely viable and safe when using the Pyrococcus furiosus ferritin (PfFtn) 
protein. No denaturation of the PfFtn monomeric subunit was observed. The choice of the 
conjugated protein is vital, especially when employing an analytical mass measurement technique 
such as mass spectrometry. Further research to be pursued in the future will employ a diverse range 
of interesting aldehydes to be conjugated to proteins and to attempt this strategy on proteins that 










4 Chapter 4: Computational Studies on the Energetics of Bioconjugation 
Reactions  
4.1 Overview  
Different bioconjugation reactions employing TFP and NHS reactive ester groups were 
carried out in the Honek laboratory and discussed in Chapter 2 of this thesis. It has been shown in 
the literature (Lockett et al., 2008), and demonstrated in this research that the TFP ester has higher 
stability in aqueous solution, as opposed to the NHS ester.  
To further expand the current understanding in regard to these observations, and during 
Covid-19 outbreak, it was decided to undertake a thermodynamic study by running theoretical 
calculations during the lockdown period away from the university. For this purpose, the molecular 
modeling and computational chemistry application, Spartan, from Wavefunction was employed in 
this study to calculate the reaction energies for bioconjugation reactions. Also, there are different 
reactive functional groups that have been used in bioconjugate techniques (e.g. nitrophenyl, methyl 
esters, sulfo-NHS, thiocyanate, carbonate, and others), besides TFP and NHS, so a range of 
reactions was studied by modeling their hydrolysis and simple amine reactions (aminolysis). The 
hydrolysis and aminolysis reactions are to mimic the reactions of these groups in empirical 
experiments with water and the nucleophilic amine from lysine residues, respectively.  
Quantum chemical computations were implemented to calculate the energies of these 
functional groups. Initially, all these reactions were modeled in the gas phase. Likewise, the 
computational calculations are feasible to be performed with aqueous environment as well, but it 
will be more complicated which could be further looked at in future theoretical computations. 
Choosing the gas phase to model the reactions will assist in gaining an insight about the inherent 
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properties of the molecules by removing the extraneous complexity associated with theoretical 
water molecules.   
 In this project, thermochemical recipes and density functional models were employed in 
the Spartan software. Thermochemical recipes are a combination of quantum chemistry methods 
that calculate and reproduce empirical heats of formation (Ohlinger et al., 2009). Density 
functional models (DFT) evaluate and describe the energy of the molecules as a universal function 
of their electron charge density (Bagayoko, 2014). The DFT models are supported with a wide 
range of basis sets for multiple demands. 
4.2 Methods  
4.2.1 Thermochemical recipes  
Thermochemical recipes were employed to calculate the heat of formation (kJ/mol) energy 
values for this set of reactions, by which the calculations were performed in the gas state. The 
widely used calculations models in thermochemical recipes, both T1 and G3(MP2) were selected. 
Only uncharged molecules were accommodated when using the T1 model. The molecular 
geometry was taken into consideration, where the “equilibrium conformer” setting was assigned 
in the T1 calculations, as this option is not applicable with the G3(MP2) model. The T1 method as 
incorporated in Spartan consists of:  
A) HF/6-31G* optimization  
B) RI-MP2/6-311+G(2d,p)[6-311G*] single point energy with dual basis set 
C) An empirical correction using atom counts, Mulliken bond orders, HF/6-31G* and 
RIMP2 energies as variables 
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4.2.2 Density Functional Models  
DFT calculations were carried out employing the functionals; M06-2X with the basis set 
6-311+G(2df,2p) for single point calculations, and B3LYP with the basis set 6-31G* for geometry 
optimization. Likewise, the DFT calculations were implemented in the gas phase as well, and the 
“equilibrium conformer” setting was specified for each reaction. 
4.3 Results and Discussion 
The complexity of the molecular system of interest dictates the type of calculations 
employed in a theoretical chemistry project. Herein, a set of reactions involving molecules with 
relatively small atomic mass units were studied, therefore, the thermochemical recipes and the 
DFT calculations that are applicable to small molecular weight molecules, were employed. A 
combination of various functional groups involved in bioconjugation reactions is presented in the 
reaction schemes below.  
The results shown in this section are of the following groups; phenyl ester (F1-F2), fluorine 
substituted phenyl esters (F3-F16), acetyl chloride (Cl1-Cl2), sulfo-NHS (SO3H-1, SO3H-2), 
nitrophenyl (NO2-1, NO2-2), methyl acetate (MA-1,MA-2), thioester (TE1-TE2), and N-
hydroxysuccinimide ester (NHS-1, NHS-2). The theoretical computations involved energy 
calculations of the hydrolysis and aminolysis of these molecules, mimicking the nucleophiles; 
water and amines. Other reactions of interest to this project were considered as well. Schiff base 
formation (OR1), methyl maleimide reactions with tris-2-carboxyethyl phosphine (TCEP) and tris-
hydroxypropyl phosphine (THPP) (OR2-OR5), methyl maleimide-TCEP adduct with 

















Scheme 4.4. Reactions of trifluorophenyl esters. 
 
 





























Scheme 4.11. Reactions of thioesters. 
 
 
Scheme 4.12. Reactions of N-hydroxysuccinimide esters. 
  
 
Scheme 4.13. Schiff base formation. 
 




Scheme 4.15. NEM-THPP formation. 
 
 











Scheme 4.17. Wittig reaction forming E- and Z-alkenes. 
 
 
First, the T1 and G3(MP2) calculations were performed. The calculations using the T1 
recipes have a reduced computational cost and time compared to the G3(MP2) protocol, but the 
energy values exhibited similar accuracy. This is determined in the comparison presented in Table 
5. It was important to assign the best molecular conformation before starting the calculations. The 
equilibrium conformer setting in T1 calculations performed a systematic search for possible 
conformations in order to choose the lowest energy conformer and used that to calculate the heat 
of formation. Whereas, G3(MP2) used the existing conformer and optimizes its geometry before 





Table 5. Calculated energy values using the thermochemical recipes models 
Reaction T1  G3(MP2)  
ΔE (kJ/mol) ΔE (kJ/mol)    
F1 -3.89 -2.35 
F2 -25.58 -27.87 
F3 -2.45 -0.18 
F4 -24.14 -25.7 
F5 -7.15 -4.67 
F6 -28.84 -30.19 
F7 -6.83 -5.35 
F8 -28.52 -30.87 
F9 -5.03 -1.84 
F10 -26.72 -27.36 
F11 -4.87 -3.13 
F12 -26.56 -28.65 
F13 -8.01 -5.64 
F14 -29.7 -31.16 
F15 -5.81 -3.25 
F16 -27.5 -28.77 
Cl1 -43.00 -38.25 
Cl2 -64.73 -63.77 
SO3H-1 8.47 15.91 
SO3H-2 -13.22 -9.61 
NO2-1 -7.89 -6.05 
NO2-2 -29.68 -31.57 
MA-1 19.45 22.65 
MA-2 -2.28 -2.87 
TE1 -10.29 -5.82 
TE2 -32.02 -31.34 
NHS-1 5.38 9.67 
NHS-2 -16.35 -15.85 
OR1 -14.26 -17.6 
OR2 -86.03 NA 
OR3 -99.95 NA 
OR4 -223.74 NA 
OR5 -245.45 NA 
OR6 -146.21 NA 





The DFT calculations were carried out next. The density functionals offer and employ a 
variety of different data sets in the model’s database. For this part of the study, the M06-2X 
functional was chosen as it provides a good performance for calculations of reaction energies and 

















Table 6. Calculated energy values using the DFT models 
Reaction DFT: M062X/6-311+G(2df,2p) - B3LYP/6-31G*  
ΔE (kJ/mol) ΔG (kJ/mol) ΔH (kJ/mol)     
F1 -17.88 -14.68 -12.18 
F2 -36.13 -31.03 -35.20 
F3 -15.19 -11.16 -9.42 
F4 -33.44 -27.51 -32.43 
F5 -21.21 -20.56 -14.48 
F6 -39.46 -36.91 -37.50 
F7 -23.23 -20.91 -16.26 
F8 -41.48 -37.26 -39.27 
F9 -18.28 -19.27 -11.64 
F10 -36.48 -43.13 -34.48 
F11 -20.56 -20.62 -13.94 
F12 -38.76 -44.47 -36.78 
F13 -23.72 -24.67 -16.87 
F14 -41.95 -47.41 -39.51 
F15 -20.57 -23.08 -13.89 
F16 -38.8 -45.82 -36.53 
Cl1 -43.74 -41.72 -45.17 
Cl2 -61.99 -58.07 -68.19 
SO3H-1 -7.58 -6.84 -1.77 
SO3H-2 -25.83 -23.19 -24.78 
NO2-1 -25.68 -25.75 -18.69 
NO2-2 -43.93 -42.10 -41.71 
MA-1 15.04 19.26 18.74 
MA-2 -3.21 2.90 -4.28 
TE1 -17.17 -26.96 -15.46 
TE2 -35.41 -43.31 -38.48 
NHS-1 -6.53 -7.48 0.28 
NHS-2 -24.78 -23.84 -22.74 
OR1 -3.47 -2.3 -9.8 
OR2 -94.39 -10.41 -85.17 
OR3 -104.7 -35.32 -96.92 
OR4 NA NA NA 
OR5 NA NA NA 
OR6 -148.87 -152.89 -146.58 




Based on the energy calculations shown in Table 5 and 6, these computational data 
conclude that the thioester (TE2, ΔE = -32.02 kJ/mol) is the most thermodynamically favorable 
reactive ester group, and that NHS ester (NHS-2, ΔE = -16.35 kJ/mol) is less thermodynamically 
favorable than the TFP ester (F14, ΔE = -29.7  kJ/mol), which is in a good alignment with our 
experimental observations. Additionally, it is noticed throughout the data set that the reactions 
with the nucleophilic amines are more thermodynamically favorable than the reaction with water. 
A comparison between the energies of the activated esters id shown in Figure 4.1.  
 
Figure 4.1. The energies of activated esters (kJ/mol). 
 
The results also show that the E-isomer is of lower energy and is more likely to be the 
product of Wittig olefination than the Z-isomer, in the reaction of maleimide-TCEP and 
benzaldehyde. This is consistent with the literature discussed in Chapter 3 concerning the type of 
the product isomer. Further work would be necessary to calculate the energies for the discussed 
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5 Chapter 5: Summary and Future Directions 
 
Over the course of this thesis research, multiple subprojects were conducted to expand the 
current knowledge on the protein networks functionalities and bioconjugation strategies. The 
protein network material we designed aim to expand the scope for industrial and medical 
applications. Figure 5.1 illustrates the full picture of the thesis project’s methodical plan. The 
project hypothesized that using these protein networks would provide enzymatic, photocleavable, 
and magnetic functionalities. Throughout the project, the materials have demonstrated substantial 
results, enabling them to serve as an efficient plastic degrading material and a smart bandage.  
 




An array of countless creative approaches could be pursued via the maleimide conjugation 
for immobilization applications. Figure 5.2 displays three potential advantages of conjugating a 
maleimide containing molecule (e.g. protein, enzyme, or small molecule) on a polymer-supported 
TCEP resin.    
 
Figure 5.2. The maleimide conjugation approach for immobilization applications. 
 
Two ferritin capsule proteins, horse spleen ferritin (HSF) and Pyrococcus furiosus ferritin 
(PfFtn) were investigated in this work as the major building blocks for the protein networks. In the 
first part of the project, the HSF was successfully bioconjugated at the exposed lysine residues 
with various potential bifunctional PEG cross-linkers that contain an activated ester (e.g. TFP or 
NHS ester) on one end and a biotin molecule on the second end that will be displayed on the 
exterior surface of the protein. The modified HSF capsules with biotins were subsequently cross-
linked with the avidin through the strongest non-covalent complexation in nature. Utilizing the 
strength and durability of the biotin-avidin interaction, in addition to the compatible choice of the 
cross-linker, these networks could demonstrate an enzymatic activity when loaded with various 
molecules. The options include but are not limited to; enzymes, photocleavable drug release when 
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choosing a corresponding linker moiety, filtration biomembrane characteristic with tunable pores 
when adjusting the expanded PEG spacer, and a lot more to be counted. Moreover, the 
sophistication of this biomaterial could be increased through occupying the empty biotin binding 
sites with biotinylated species (e.g. fluorophores, enzymes, magnetic particles, drug molecules). 
The second part of the project has investigated and successfully accomplished a novel 
bioconjugation strategy, which aimed to modify the surface lysine residues of the ferritin 
employing a multistep conjugation process that incorporated an aldehyde-containing molecule 
exploiting the Wittig reaction. The strategy utilized a small molecular weight adduct, TCEP-MAL 
that is difficult to detect a high-resolution mass peak for. Therefore, the thermally stable PfFtn 
protein was utilized in this part, since determining an accurate mass of the small molecular 
modifications in ESI-MS technique was a real challenge when using the HSF as the capsule 
protein. Pursuing this bioconjugation strategy should provide more interesting characteristics to 
the protein networks.   
Despite all the work that has been undertaken, and the promising results obtained in both 
parts of the project, there is much more to explore about the novelty of these supramolecular 
proteinaceous nanomaterials and the plethora of strategies that could be pursued to tailor the 
properties of the scaffold in order to attain the desired application.  
5.1 Optimizations and Bioconjugation with Functional Aldehydes  
Milder conditions that require lower temperatures to drive the Wittig olefination of 
mPEG4-benzaldehyde with PfFtn will be optimized. The mild conditions will include eliminating 
the use of NaOH catalyst, because bases are not advised to be used in a proteinaceous environment. 
An alternative would be using a basic buffer solution (e.g. EPPS buffer). Furthermore, two 
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additional water-soluble aldehydes are to be labelled to proteins to add functionality. These are; 
PEG12-benzaldehyde with dansyl group that exhibits a fluorescence activity, and PEG12-
benzaldehyde with biotin group that can attach with high affinity to avidin proteins (Figure 5.3).  
 
  
Figure 5.3. Two aldehyde reagents for bioconjugation with proteins. A) PEG12-benzaldehyde 
with dansyl group that exhibits a fluorescence activity. B) PEG12-benzaldehyde with biotin 
group that can attach robustly with avidin proteins. 
 
5.2 Immobilizations on Polymer-supported TCEP Resins 
An array of various approaches could be pursued by utilizing the TCEP-MAL reaction 
strategy to make new biomaterials. The future work will include the immobilization of proteins 
using “Immobilized TCEP Disulfide Reducing Gel” (Thermo Fisher Scientific, Rockford, IL, US), 
a polymer-supported TCEP-containing resin made of cross-linked agarose gel. A protein modified 
with maleimide can react with the TCEP forming the adduct to be attached to the resin. An 
aldehyde molecule will be used to release the protein from the resin. Not only capsule proteins 
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could be incorporated in this direction, but also non-capsule proteins would add a new dimension 
to the proposed idea. The enzyme bovine carbonic anhydrase (BCA) that catalyzes the conversion 
of carbon dioxide and water to bicarbonate ions (Saito et al., 2004), will be modified with 
maleimide groups and attached to the TCEP resins. In addition to its common function, BCA has 
been found to catalyze the hydrolysis of p-nitrophenyl ester to p-nitrophenol (Pocker et al., 1974) 
that absorbs 405 nm wavelength, so this functionality will be exploited in this context. The 
immobilization method should increase the concentration of the catalytic molecule and perhaps 
increase the stability of the immobilized enzyme. This new bioconjugation technique is to be 
enabled by employing the agarose resins to serve as a biorenewable platform for the formation of 
new materials with sustainable building blocks.  
5.3 Computational Studies  
Future work will include transition state modelling. The plan is to compare the energies of 
the substrates and the transition states to be able to explain what is contributing to the capability 
of the TFP esters to remain intact longer in aqueous solution. Transition state modeling was carried 
out by our group intensively using Spartan (Wavefunciton Inc.) and AutoTS (Schrodinger, LLC) 
software. Some challenges were faced in the preliminary work, so the future work will include 
further studies to successfully calculate transition state energies. Previous literature reported 
comparative studies on the hydrolysis rates between TFP and NHS, however, no studies on the 
thermodynamics of the functional groups were found in the literature.  
In regard to the transition state modeling, there is a second aspect that our group is 
interested in revealing in the future work. Tris-2-carboxyethyl phosphine (TCEP) and Tris-
hydroxypropyl phosphine (THPP) are both soluble reducing agents, however, each one has been 
shown to produce different products (Scheme 5.1). As this research states, TCEP was determined 
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to produce a stable adduct when reacted with maleimide. On the other hand, THPP tends to reduce 
the maleimide to succinimide (Kantner & Watts, 2016). The reason for yielding different products 
has not been uncovered yet. It is difficult to interpret this observation in terms of the charge and 
the induction differences between the carboxyl and hydroxyl functional groups, since both 
compounds have a very similar pKa value for the phosphorous atoms of the TCEP and THPP (pKa 
= 7.7 and 7.2, respectively) (Kantner & Watts, 2016). The Honek group will be working on the 
computational study to model the transition state of both reagents, hoping that will provide some 
insight.   
 
Scheme 5.1. The reaction of N-ethylmaleimide with TCEP produces an ylene, while its reaction 
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